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MOTIVATIONAL INTERVIEWING: DOES IT INCREASE ALCOHOL AND 
OTHER DRUG ADDICITED RETENTION IN TREATMENT 
David A. Patterson 
April 20, 2006 
This dissertation is a post-test only comparison group study. It tests the 
effects of additional Motivational Interviewing sessions during the first two weeks 
in an intensive outpatient clinic. The object is to learn whether these additional 
sessions will help to increase rates of treatment retention and completion with 
alcohol and other drug addicted individuals as well as those who are dually 
diagnosed with HIV/AIDS infection and addiction. It begins with the problems 
associated with alcohol and other drugs followed by problems related to 
HIV/AIDS and treatments for both illnesses. It uses Transtheoretical Stages of 
Change Model as a guide for intervention development. The latter part of the 
dissertation describes the method used to study this population and the results. 
The dissertation is divided into five chapters. Chapter I discusses the 
problems associated with alcohol and other drug addiction and HIV/AIDS 
followed by treatments related to those illnesses. Chapter II begins with 
reviewing the literature linked to treatment retention. This chapter identifies the 
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theoretical perspectives of treatment retention and completion followed by an 
intervention development using Motivational Interviewing sessions as a means to 
address treatment retention and completion.  
While Chapters I and II are descriptive and theoretical in nature, Chapter 
III focuses on designing a study to test the effects of an intervention on retention 
and completion. It lays out the methodology of the study such as its purpose, 
design, instruments, sample and variables. Chapter IV discusses the results of 
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This dissertation was conducted within an intensive outpatient (IOP) clinic 
at the Volunteers of America (VOA) of Kentucky Inc. The IOP clinic has existing 
research infrastructure that is funded by a Substance Abuse and Mental Health 
Services Administration’s (SAMHSA) Center for Substance Abuse Treatment 
(CSAT) grant. The grant enabled the Volunteers of America to establish an IOP 
clinic specifically to treat individuals with alcohol and other drug addiction, which, 
according the SAMHSA also places them at a higher risk for HIV-infection.  
The primary aim of the study is to test the effects of up to five Motivational 
Interviewing (MI) sessions on treatment retention and completion delivered 
during the first two weeks of treatment. A post-test only design with comparison 
group—the treatment group (IOP + up to 5 MI sessions) and comparison groups 
(IOP only)—was conducted. While the intention was to test the effects of a MI 
intervention with those subjects with alcohol and other drug (AOD) addiction 
seeking IOP services, there was also an attempt to enroll subjects who were 
dually diagnosed with AOD addiction and HIV/AIDS infected. 
This dually diagnosed population (i.e., AOD addicted and HIV/AIDS 
infected) comprises a much smaller segment within the entire sample, but one 
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that needs to be studied in order to address their needs during AOD treatment. 
Enrolling and analyzing these subjects will be guided by Rounsaville, Carroll, and 
Onken’s (2001) Stage 1b pilot trial study. The Stage 1b allows for a limited 
number of subjects for pilot studies, 15 to 30 per cell along with establishing 
treatment efficacy and support for larger clinical trials. 
The Problem 
Alcohol has played a major role in people's lives throughout history. 
Alcoholic beverages in our society have been consumed with meals, served for 
medicinal or religious purposes, used to celebrate special occasions, and served 
as a social facilitator. While most individuals who drink alcohol do not develop 
problems with, or dependence on, alcohol, many social workers encounter high 
rates of alcohol problems among the clients they serve. Alcohol problems refer to 
any situation caused by drinking which directly harms the drinker, places the 
drinker at risk, or places others at risk. Alcohol use problems exist on a 
continuum of severity from occasional binge drinking to alcohol abuse or 
dependence. 
This chapter opens with (a) this overview of the scope of the problems of 
addiction to AOD, and the HIV/AIDS pandemic (Human Immunodeficiency Virus 
[HIV] and Acquired Immunodeficiency Deficiency Syndrome [AIDS]). This is 
followed by (b) a discussion of the financial and human costs, (c) trends in AOD 
use, (d) the prevalence of HIV/AIDS, and (e) treatment for both addictions and 
HIV/AIDS. 
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The Alcohol and Other Drug Problem 
Alcohol abuse is described as continued drinking despite adverse effects 
on health, family, work or personal relationships, interpersonal problems, or 
alcohol-related legal problems (National Institute on Alcohol Abuse and 
Alcoholism [NIAAA], 2001). According to the NIAAA’ s web site (July, 2004) 
100,000 Americans die of alcohol-related causes each year, making alcohol the 
third leading contributor to mortality related to lifestyle in the U.S. (tobacco is first, 
and diet and activity patterns are second). Nearly 53% of the adult population of 
the U.S. (98 million persons aged 18 or older) have family histories of alcoholism 
or problem drinking (July, 2004). Approximately 6.6 million children under age 18 
live in households with at least one alcoholic parent. 
According to SAMHSA’s 2004 National Survey on Drug Use and Health, 
about half (50.3%) of Americans aged 12 years or older reported that they 
consume alcohol. This converts into an estimated 121 million Americans drinking 
alcohol on a regular basis coded into three categories of use: Current, (at least 1 
drink in the past month), Binge use, (5 or more drinks on the same occasion in 
the past month), and Heavy use (5 or more drinks on the same occasions on at 
least five different days in the past month). Almost 45% (55 million) report binge 
drinking and just fewer than 14% (17 million) are heavy drinkers. Almost 14 
million U.S. adults meet medical criteria for the diagnosis of alcohol abuse or 
alcoholism, and over 30% of high school seniors engage in binge or heavy 
drinking. 
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The Costs: Financial and Human 
The estimated costs of alcohol disorders and their social consequences in 
1998 were $185 billion. Of this sum, direct treatment and health care costs 
accounted for 14%, reduced worker productivity 47%, and lost productivity due to 
premature deaths for 20% (July, 2004). Costs associated with alcohol-related 
traffic crashes—the fifth leading cause of death for Americans of all ages—
account for 9%, as do costs associated with criminal activity. Almost 39% of 
these costs were spread across the U.S. population in the form of increased 
burden on government budgets. 
Fetal alcohol syndrome (FAS), a serious disorder affecting brain function, 
is the leading preventable birth defect in the U.S., with an estimated incidence 
rate between 0.5 to 3.0 cases per 1,000 births. A larger number of infants who do 
not present with the facial features required for a FAS diagnosis, nonetheless, 
experience alcohol-related neurobehavioral deficits caused by prenatal alcohol 
exposure (SAMHSA, June, 2004). 
While alcohol is usually studied separately from other addictive 
substances, many people who have addictions may use several other 
substances, including alcohol, marijuana, cocaine, and heroine. Nineteen million 
Americans 12 years or older reported using illicit drugs in SAMHSA’s 2004 
National Survey on Drug Use and Health; this represented just fewer than 8% of 
the U.S. population. Marijuana was the most commonly reported illicit drug used 
(14.6 million) followed by non-medical psychotherapeutic drugs (6 million), pain 
relievers (4.4 million), tranquillizers (1.6 million), stimulants (1.2 million), and 
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sedatives (0.3 million). Table 1 shows the most popular drugs. Crack cocaine, 
derived from powder cocaine, produces a euphoric high in less than 10 seconds 
and costs approximately $100 per gram. Marijuana is a plant (cannabis sativa) 
when harvested, dried and smoked causes the effect of relaxation as well as 
extreme paranoia. Marijuana is sold in multiple ways from one joint to pounds, 
which could cost up to $1,500. Alcohol’s chemical makeup consists of ethanol 
(CH3CH2OH) and is sold in various forms. When drunk, it reduces anxiety and 
causes drowsiness. Heroin is synthesized from morphine and is a central 
nervous system depressant and pain reliever. Its costs could be up to $125 per 
gram. Methylenedioxy-y-N-methylamphetamine (MDMA) commonly referred to 
as Ecstasy, produces profound positive feelings and relaxation. It is usually sold 
in pill form and can cost approximately $25 per pill. 
Alcohol and Drug use Trends 
The National Institute on Drug Abuse (NIDA, 2004) and SAMHSA have 
sponsored several national surveys to track drug use trends since the 1970s. 
One of the most widely known is the National Household Survey on Drug Abuse 
(2004), which interviewed persons age 12 and older about drug and alcohol use. 
In 1991, the survey was expanded to include civilians living on military 
installments, in college dormitories, and in homeless shelters. In 1979, 14.1% of 
the population age 12 and older reported using an illicit drug in the past 30 days. 
Between 1999 and 2001, past month illicit drug use for persons age 12 and older
5 
Table 1 
The Most Popular Drugs Abused, by Names, Chemical Makeup, Cost per 
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increased from 6.3% to 7.1%. In 2001, an estimated 0.7% of the population age 
12 and older reported using cocaine, including crack, at least once in the past 
month. Such use peaked in 1979 for 18-25-year-olds at 9.9, in 1982 for 12-17-
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year-olds at 1.9%, and in 1985 for 26-34-year-olds at 6.3%. In 2001, the 
percentage of Americans reporting marijuana use at least once in the past month 
was 5.4% of the population age 12 and older. Reported use of marijuana in the 
past month peaked in 1979 for 12-17-year-olds at 14.2%; for 18-25-year-olds at 
35.6%; and for 26-34-year-olds at 19.7%. 
The Prevalence of HIV/AIDS 
This section provides a primer on AIDS—chronicling the prevalence of 
HIV/AIDS internationally, in the United States, and Kentucky. This section closes 
by showing the devastating connection between HIV/AIDS, and addiction to 
AOD. Although there is a substantial body of literature addressing major 
milestones of the HIV/AIDS pandemic since its beginning (Bawa, 2005; del Rio, 
2005; Genuis & Genuis, 2005; Shilts & Greider, 2000), discussion will be limited 
to the above stated issues. 
HIV/AIDS Internationally 
Current estimates are that 38 million people were living with HIV infection 
at the end of 2003 and that the epidemic continues to expand in almost all 
regions of the world, with approximately 4.8 million new infections in 2003 (Joint 
United Nations Programme on HIV/AIDS, 2004). The burden of disease in this 
pandemic is disproportionately high among women and those who live in poverty. 
The proportion of infected persons who are women has increased steadily so 
that now more than 50% of those living with HIV are female. Adolescents and 
young adults aged 15-24 years account for half of all new infections worldwide, 
and girls and young women are particularly vulnerable. In Sub-Saharan Africa, 
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women account for 57% of infected adults and 75% of the infections in young 
adults. Though a large proportion of HIV-infected adults in the U.S. are men, 
women now account for 25% of all HIV infections in North America (CDC, 2004a; 
CDC, 2004b; Kaiser Family Foundation, 2004). 
HIV/AIDS in the United States 
The HIV/AIDS epidemic continues to be a major problem for U.S. citizens 
with approximately 1 million Americans HIV/AIDS infected (CDC, 2002). 
According to the Centers for Disease Control and Preventions (CDC, 2002) AIDS 
incidence increased throughout the 1980s, declined from the mid-1990s through 
2001, and increased 2% in 2002 (over 2001). AIDS prevalence, or the number of 
persons living with AIDS in the U.S., continues to increase and was estimated to 
be 384,906 at the end of 2002 (CDC, 2002). Although HIV has historically been 
most prevalent among men who have sex with men (MSM, Bacon et al., 2006; 
Catania, Osmond, & Stall, 2002; Celentano et al., 2006), most new HIV infections 
are reported among MSM who are also injection drug users. The proportion of 
HIV cases acquired through heterosexual contact has also increased, and is 
equal to the proportion of cases attributed to injection drug users (CDC, 2002; 
Karon et al., 2001). 
Some minority groups within the U.S. are also disproportionately affected. 
For example, approximately 50% of those living with HIV/AIDS are Black and 
10% are Hispanic (Kentucky HIV/AIDS Surveillance Report, 2002; Zaidi et al., 
2005). The geographic distribution of people living with AIDS has also changed 
as the epidemic has become more generalized. By the end of 2002, 39% of 
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persons living with AIDS in the U.S. resided in the South, 29% in the Northeast, 
19% in the West, 10% in the Midwest, and 3% in the U.S. territories (Kentucky 
HIV/AIDS Surveillance Report, 2002). 
Reports of women being infected with HIV has tripled since mid-1980, 
mainly resulting from heterosexual exposure and secondarily through injection 
drug use (CDC, 2002). Minority groups are the most affected by HIV associated 
with drug injection and Blacks and Hispanics account for approximately 70% of 
all new U.S. AIDS cases (CDC, 2002). 
HIV/AIDS in Kentucky 
The prevalence of HIV/AIDS in Kentucky is comparable to national trends. 
As of December 31, 2004 there have been 4,119 AIDS cases reported in 
Kentucky to the Department for Public Health’s HIV/AIDS surveillance system. Of 
these reported cases, only 2,245 were still reported as living as of 2004. In 2003, 
there were 195 new AIDS cases diagnosed. As of December 2004, 158 new 
AIDS cases were diagnosed and reported to the Kentucky HIV/AIDS surveillance 
programs in 2004. Kentucky ranked 31st among the United States in the number 
of AIDS cases reported in 2002 (7.5 per 100,000). 
The Kentucky HIV/AIDS Semi-Annual Report (2004) presents data 
regarding AIDS cases diagnosed and reported to the Kentucky Department for 
Public Health, HIV/AIDS Program through December 31, 2004. Kentucky, 
however, did not report HIV cases until last year and is currently updating its 
reporting system to reflect both HIV and AIDS. According to state regulation 902 
KAR 2:020, Section 7 of the Kentucky Annual Report (KAR), health professionals 
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licensed under KRS chapters 311 through 314, health facilities licensed under 
KRS Chapter 216B and laboratories licensed under KRS Chapter 333 are 
required to report HIV and AIDS cases to the Kentucky Department for Public 
Health within five business days of diagnosis. AIDS cases are reported by name, 
while HIV cases were previously reported by a unique identifier consisting of the 
person's initials of last and first names, date of birth, and last four digits of their 
Social Security numbers.  
However, the reporting system for HIV cases has changed. On July 13, 
2004 new HIV/AIDS reporting requirements were adopted in Kentucky to include 
reporting for HIV using a confidential name based reporting system. According to 
902 KAR 2:020 Section 7, HIV cases are to be reported by name, gender, race, 
and risk factor as identified by the CDC. Data from the HIV confidential name 
based reporting system, which was implemented as a result of these 
requirements, will not be released until a complete evaluation of the system has 
been completed. HIV tests can be either anonymous or confidential; however, 
only confidential HIV positive cases are reported to the Kentucky Department for 
Public Health. This new system of reporting will provide the state with more 
accurate data on those who are HIV-infected and not just limited to only reporting 
AIDS cases. 
Demographic Trends 
The Kentucky 2004 HIV/AIDS Semi-Annual Surveillance Report (2004), 
which just accounts for AIDS reported cases (not HIV), indicates that 80% of all 
Kentucky AIDS cases reported are male, 20% female. AIDS cases by race show 
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that the majority of infected individuals are White (58%), with African Americans 
making up 35% of AIDS cases while representing only 7.3% of the state’s 
population (U.S. Census Bureau, 2004). Almost half of the state’s AIDS patients 
(46%) were reported to live in the North Central region of the state, which 
includes the Louisville Metro area. Cases reported by risk factors in 2004 
indicated that men who have sex with other men are at the highest risk (47%) 
followed by intravenous drug users (17%), and risk factors for 16% were 
undetermined. In 2002, the AIDS rate for African-Americans was approximately 
seven times higher than for whites in Kentucky. The AIDS incidence rate for 
African Americans has been gradually declining since 2000 with a slight increase 
observed in 2001. The AIDS rate among white Americans, which had steadily 
declined since 1996, increased for the first time in 2001 and continued through 
2002. Overall, AIDS rates for white Kentuckians has remained relatively stable. 
The AIDS rates for African-American males in Kentucky are seven times higher 
than white males in Kentucky and African-American females in Kentucky have 
AIDS rates 13 times higher than white females in Kentucky (Kentucky 2004 
Kentucky HIV/AIDS Semi-Annual Surveillance Report). 
In 2002, AIDS was the 22nd leading cause of death for all Kentuckians. 
AIDS was the 11th leading cause of death in African Americans and the 25th 
leading cause of death of Whites in Kentucky (Kentucky 2004 HIV/AIDS Semi-
Annual Surveillance Report). For African American males in Kentucky, AIDS 
ranked as the 9th leading cause of death. In 2002, among those ages 25-44, 
AIDS was the 6th leading cause of death. Among those ages 25-44, AIDS 
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ranked as the 2nd leading cause of death for African American males, 7th among 
white males, 5th among African American females, and 11th among white 
females. In 2002, death rates among 25-44 year old White males and females 
increased while death rates among 25-44 year old African-American males and 
females decreased (Kentucky HIV/AIDS Semi-Annual Surveillance Report, 
2004).  
In 2004 the largest number of AIDS cases (46%) residing in Kentucky at 
the time of diagnosis were in the North Central Area Development District (ADD), 
which includes the Louisville Metro area (Figure 1). The Bluegrass ADD had the 
second largest number of AIDS cases (19%) reported in Kentucky, which 
includes the city of Lexington, followed by the Northern Kentucky ADD with the 
third largest number of AIDS cases (8%) reported in Kentucky (Kentucky 2004 
HIV/AIDS Semi-Annual Surveillance Report, 2004). 
 
Figure 1. Number of AIDS cases in Kentucky. 
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This supports findings that those who use alcohol are more likely to 
engage in behaviors that place them at higher risk for contracting HIV/AIDS 
(Metzger, Navaline, & Woody, 1998; Stein, Hanna, & Natarajan, 2000); Windle, 
1997). There are high rates of intravenous drug users among alcoholics in 
treatment (Metzger et al., 1998) and drug-related risk behavior, i.e. needle 
sharing and unprotected sex, increase along with the increase of alcohol 
ingestion (Stein, Hanna, & Natarajan, 2000). There is also a link between a 
history of heavy AOD use (Baseman et al., 1999; Deren et al., 1996; Hansen et 
al., 2002; Logan et al., 2003; Surratt, Inciardi, Kurtz, & Riley, 2004) and the 
tendency toward a lifetime of high-risk sexual behaviors, which include multiple 
sex partners, unprotected intercourse, sex with high-risk partners, and the 
exchange of sex for money or drugs (Avins et al., 1994; Boscarino et al., 1995; 
Windle, 1997). 
The Importance of Studying Addiction & HIV/AIDS Together 
The role played by alcohol consumption as a facilitator of HIV/AIDS 
infection risk has been the subject of much research. A relationship between 
alcohol use and HIV/AIDS risk has been documented among men who have sex 
with men (Bacon et al., 2006; Celentano et al., 2006; & Koblin et al., 2003), urban 
minority groups (Norris & Ford 1999), adolescents (Kerr & Matlak, 1998), HIV-
seropositive individuals (Marks, Crepaz, Senterfitt, & Janssen, 2005), seriously 
mentally ill persons (Tucker et al., 2003), and non-U.S. populations. 
Twenty-nine to 60% of HIV-infected patients develop an AOD addiction at 
some point in their lives—a rate roughly three times as high as that of the U.S. 
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population (Meyerhoff, 2001). According to Petry (1999), the prevalence of 
addiction among current HIV-infected individuals is nearly 12%--approximately 
twice the rate of the general population. 
The connection between alcohol and other drug addiction and HIV/AIDS 
has been established, including the role of AOD use in the continuing spread of 
HIV/AIDS. The Center for Substance Abuse Treatment (2002) identified five 
important issues related to AOD and HIV/AIDS: (a) substance abuse increases 
the risk of contracting HIV due to the association between the use of dirty 
needles and engaging in risky sexual behaviors in exchange for drugs and/or 
money, (b) substance abuse increases risks for obtaining substances while 
under the influence or while under coercion, (c) substance abuse and HIV/AIDS 
both serve as potential catalysts or obstacles in the treatment of the other, (d) 
substance users who inject drugs represent the largest HIV-infected population in 
the U.S., and (e) putting clients in substance abuse treatment, along with a 
continuum of care, minimizes the risk of substance abuse and HIV infection 
(2002). In order to stop the spread of HIV/AIDS without a vaccine, those who are 
infected with the disease must stop passing it along. One of the best ways to 
stop the spread of the disease is for patients to enter and engage in treatment 
that lowers the risks for exposing others.  
Treatments 
This section chronicles the history of treatment for alcohol and other drug 
addictions and the three main levels of treatment. The history of treatment for 
HIV/AIDS is then described, and finally, the complexity of treating individuals 
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unfortunate enough to need treatment for both conditions—addiction and 
HIV/AIDS—is briefly addressed. While there are other exclusive bodies of 
literature regarding addiction to and treatments of specific, individualized 
substances such as nicotine (i.e. Lancaster & Stead, 2006; Roozen et al., 2006) 
or opiate addiction (i.e. Ashworth, 2005; Sorensen et al., 2005) those distinctive 
addictions are not addressed in this study.  
The History of Addiction Treatments 
The addiction treatment field in the U.S. has a history of disagreeing about 
the best model or design for treating the addicted individual, resulting mainly from 
the disagreement about the causes of addiction. Alcoholism’s causes have been 
rooted in personal choice (Fingarette, 1988), sociocultural influences (Cahalan, 
1987), family of origin pathologies (Steiner, 1971), and social learning (Peele, 
1985), as well as biochemical dysfunctions (Milam & Ketcham, 1981). Alcohol is 
one of the oldest, most often used drugs. The problems associated with using 
alcohol are described in the Bible: 
Whose heart I filled with anguish and sorrow? Who is always fighting and 
quarrelling? Who is the man with bloodshot eyes and many wounds? Is it 
the one who spends long hours in the taverns trying out new mixtures. 
Don’t let the sparkle and the smooth taste of strong wine deceive you. For 
in the end it bites like a poisonous serpent; it stings like an adder. You will 
see hallucinations and have delirium tremens, and you will say foolish, 
silly things that would embarrass you no end when sober. You will stagger 
like a sailor tossed at sea, clinging to a swaying mast. And afterwards you 
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will say. I didn’t even know it when they beat me up . . . let’s go and have 
another drink. (Proverbs 23: 29-35, The living Bible) 
Just as the problems connected to drinking alcohol have a long history, so do the 
proposed solutions. One of the oldest solutions has been to modify individuals’ 
behavior and moral codes. This moral perspective sees drinking as a willful act 
that violates socially acceptable norms, but which can be controlled by individual 
choice (Connors & Rychtarik, 1989). The moral view of addiction remains 
prevalent today (just say no) resulting in the civilization of addiction and the ever-
increasing prison population. 
Following the moral viewpoint of addiction was the temperance movement 
that emphasized controlled use of alcohol. As the use of alcohol began to spread 
and people in the late 18th century and into the 19th century died from alcoholism, 
the temperance movement changed from moderation of consumption to total 
abstinence (Maxwell, 1950). The viewpoint stemming from the temperance 
movement was that the cause of alcohol problems was the presence of alcohol. 
The natural progression from this perspective was to ban the manufacture, sale, 
transportation, and importation of alcohol, better known as the 18th Amendment 
to the Constitution and the beginning of prohibition. While alcohol consumption 
decreased under prohibition, the law was difficult to enforce and widely 
unpopular and ignored.  
A few years after the repeal of prohibition, Alcoholics Anonymous (AA) 
was founded in 1935 by two alcoholics who were attempting to recover on 
spiritual principles—a stockbroker and a physician. One of the founders, Bill 
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Wilson, had experienced a spiritual awakening resulting from his experience with 
the Oxford Group fellowship, a religious movement that thrived briefly in the 
1930s. The Oxford Group meetings consisted of small group discussions where 
confessions, talking out emotional problems, and praying to God took place 
(Trice, 1958). While the Oxford movement was centered on a religious 
conversion, AA (n.d.) began to see alcoholism as an illness—the moral crusade 
was coming to an end. 
Around the same time, the medical community became interested in 
alcoholism. In an attempt to study alcohol problems through scientific work, the 
Research Council on Problems of Alcohol was established in New York (Keller, 
1976). While the research council did not receive any funds to study the 
problems associated with alcohol, it did result in de-moralizing the problem and 
set the stage for the federal government to create a bureaucracy around 
alcoholism. The first federal fund established to deal with alcohol problems was 
the National Institute of Alcohol Abuse and Alcoholism (NIAAA) and within a 
short period of time millions of dollars were directed toward combating 
alcoholism.  
Current Treatments 
Addiction treatment is currently designed to begin with medically 
supervised detoxification, followed by some type of rehabilitation services lasting 
from a few weeks up to possibility more than a year. The criteria for diagnoses 
using the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 
(American Psychiatric Association, 1994), requires the presence of three or more 
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of the following: increased tolerance (can hold more and more), withdrawal, 
drinking alcohol in larger amounts, the desire to cut down the amount of alcohol 
use, a great deal of time invested in obtaining or using alcohol, reducing social 
activities that include drinking alcohol, and continued use despite physical or 
psychological problems. 
The three levels of care for the treatment of addiction are inpatient, 
intensive outpatient (IOP), and outpatient. All three levels include activities such 
as group and individual counseling, addiction education sessions, basic life skills 
education, and engagement with 12-step meetings. Inpatient treatment is the 
highest level of care—residential services lasting approximately one month. 
Intensive outpatient services may include daily and possibly weekend services 
lasting several hours per day over a period of many months. Outpatient treatment 
is the lowest level of care and is designed for those who work and have stable 
employment and social supports.  
The History of HIV/AIDS Treatments 
Although the virus was initially identified in the 1980s the infection in 
human beings probably originated as early as the 1950s, spreading in an 
epidemic way in the 1970s (Zhu et al., 1998). While there are many theories 
concerning the exact origin of HIV, Gao et al.,(1999) recently discovered a 
subspecies of chimpanzees in Africa carrying the HIV-1 virus, which was 
introduced to humans and is responsible for the current pandemic. The 
researchers concluded that hunters were exposed to infected blood. The first 
cases of AIDS during the 1980s puzzled physicians because healthy young 
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homosexual men were showing up in hospitals with the presence of a rare 
infection found only in severely immunocomprimised people. Several cases were 
published identifying pneumonia from Pneumocystis carinii, an ordinary organism 
rarely causing infection, along with invasive Kaposi sarcoma, a strange cancer 
that was usually localized (Treisman & Angelino, 2004). In the early years of the 
disease, treatment focused mainly on palliative care—keeping the patient 
comfortable. Although HIV infection continues to have a dismal outcome, in the 
early 1990s, antiretroviral drugs were developed and prescribed. One of the first 
drugs used was Azidothymidine (AZT), which added about 18 months to the lives 
of HIV-infected individuals (Treisman & Angelino, 2004). 
As research progressed and new drugs entered the market, 
pharmaceutical treatments consisted of a cocktail of drugs regimented for 
effectiveness. This highly active antiretroviral therapy, better known as HAART, 
had to have 90% compliance to the regimen in order to be effective (Treisman & 
Angelino, 2004). With these antiretroviral therapies, people with HIV/AIDS can 
have lively, productive lives. The Ryan White Act provides funds for addiction 
treatment but it is totally separate from medical care. Unfortunately, little is known 
about the effectiveness of many treatment approaches—one of the reasons for 
this study. 
Combining Addiction and HIV/AIDS Treatment 
Because both of these conditions are complex and chronic by themselves, 
it is important to have experienced AOD practitioners on staff when treating 
addicted HIV-infected individuals. Integrating care for addicted HIV-infected 
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individuals is, at best, difficult. Regardless of whether they enter medical care or 
alcohol and drug treatment and due to limited training, providers may disagree on 
which chronic disease has priority (Patterson et al., 2004). In order to accomplish 
integrated care for addicted HIV-infected persons, connections must be made 
between the two providers, which enhance access to care and expansion of 
integrated services (Selwyn & O’Connor, 1992). 
Alcohol and drug treatment providers should be able to conduct HIV risk 
assessments, provide basic HIV education and counseling, and provide HIV 
testing with pre- and posttest counseling (CDC, 1993). The staff within the 
primary medical care facility should ask questions regarding alcohol and drug 
use, have cultural competence training, and reinforce the message to patients 
that any AOD use damages their overall health and is cause for referral to be 
assessed for alcohol and drug problems (Patterson, 2004). Unfortunately, 
integrated services are few and far between. While there has been an attempt at 
medical and alcohol and drug providers working together, this type of 
recommended care is still nonexistent in the Louisville, Kentucky area. 
The next chapter provides a comprehensive review of relevant literature. 








REVIEW OF RELATED LITERATURE 
This chapter first focuses on treatment retention and completion for both 
populations under study (those addicted to AOD and persons with HIV/AIDS). 
Theoretical perspectives are then examined and Motivational Interviewing as an 
intervention to increase retention is presented. This chapter closes with 
explication of the gap in the professional literature that this study is designed to 
address. 
Treatment Retention and Completion Linked to Better Outcomes 
Research links treatment retention and completion to lower alcohol use, 
which in turn, decreases the risk for spreading HIV (e.g., Basso & Bornstein, 
2000; Moos, 2003). Treatment retention and completion have been consistently 
confirmed to improve outcomes (e.g., Hubbard et al., 1996; Simpson, 1981). 
Since time in treatment and treatment completion are generally associated with 
more successful outcomes, identification of factors related to treatment retention 
is important. Unfortunately, however, treatment dropout in the U.S. is also a well-
known phenomenon. According to Hubbard et al.,(1989), approximately 82% of 
the clients in outpatient, drug free programs drop out before completing 
treatment. More recent findings of high dropout rates across treatment modalities 
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indicate that clients usually do not remain in treatment for more than a couple of 
weeks (Anglin & Hser, 1990). 
Rationale for Studying Retention 
Retention and completion of addiction treatment have been widely 
recognized as factors contributing to improved post treatment alcohol and other 
drug abstinence. While adaptations of Motivational Interviewing (Miller & Rollnick, 
2002) have demonstrated promise in improving treatment adherence, including 
retention (Zweben & Zuckoff, 2002), no studies on methods were found to 
improve retention and completion among those who were HIV-infected. Given 
the established health threat related to the spread of AIDS by those who are 
dually diagnosed with HIV-infected and actively abusing alcohol, this is a serious 
concern (Basso & Bornstein, 2000). Thus, the overall purpose of the study is to 
test the effects of up to five motivational interviewing sessions on the retention 
rates for addicted HIV-infected individuals entering an intensive outpatient 
alcohol and drug treatment program. 
Retaining HIV-Infected Alcohol Dependent Individuals in Treatment 
Although Zweben and Zuckoff (2002) made a case for using Motivational 
Interviewing with AOD addicted individuals in order to improve their retention and 
completion, there is an absence of empirically based practice methods that focus 
on retaining HIV-infected alcohol-dependent individuals in treatment. The 
majority of studies of HIV-infected individuals with addictions center on retention 
in methadone maintenance programs.  
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 While past studies addressed HIV-infected individuals’ retention in care 
services, few dealt specifically with retaining addicted individuals in alcohol and 
drug treatment settings. The efficacy of motivational interviewing with HIV-
infected alcohol dependent individuals has not been evaluated. 
Hypotheses 
Two hypotheses were posed for this study which pertained to the paucity 
of research on the potential of MI to increase number of days in treatment:  
Therefore, the hypothesis posed and tested are: Up to five booster 
motivational interviewing sessions during the first two weeks of treatment 
increases (a) days in IOP treatment, and (b) completion rates in an 
intensive outpatient alcohol and drug treatment program in a Volunteers of 
America treatment program.  
Theoretical Perspectives on Treatment Retention 
This section provides theoretical perspectives regarding treatment 
retention. It begins with (a) Carl Rogers’ perspective, (b) Prochaska’s 
Transtheoretical Stages of Change Model, (c) Miller & Rollnick’s perspective of 
Motivational Interviewing, (d) designing an intervention using Motivational 
Interviewing, and ends with (e) the gap in knowledge.    
Carl Rogers’ Therapy and Therapeutic Relationship 
Motivational Interviewing was birthed out of Carl Roger’s approach to 
counseling. Carl Rogers’ main idea about humanity is that every one of us has 
one ultimate motivating force – self-actualization. He defined this event as the 
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inherent tendency of the organism to develop all its capacities in ways that serve 
to maintain or enhance the organism (1951, 1961, & 1980).  
According to Rogers we are born with a positive valuing process that 
enhances and maintains the positive things in our lives, and devalues negative 
experiences that stagnate our growth potential. With this internal process that is 
part of our inherent design, we trust that they intend to serve us well. Rogers 
concluded that our worlds are products of our own making (our realities) and that 
in order for someone else to understand our real reality they must attempt to 
place themselves in our frame of reference (1951, 1961, & 1980). Once we 
understand ourselves, we seek positive regard for that self. People learn to need 
others and to be needed, loved, prized, and accepted. These needs are addictive 
and can become the most important thing in becoming a person. 
For instance, when parents respond to children’s behaviors with positive 
reflection, the children see that their behavior evoked a pleased parent and they 
try to do it again. But if parents respond negatively, children see their loving 
relationships with their parents weakening. Before long, as children grow, they 
see themselves as others regard them. This results in individuals seeing 
themselves as more or less worthy, depending on the responses they received 
from their parents and others. 
Individuals with maladjusted conditions of worth are threatening to 
themselves. Because we all deserve full self-actualization and to become whole 
persons, if our behavior is conflicted with the self we like and the self we dislike,  
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then we have divided personalities that can result in dysfunction (1951, 1961, & 
1980). 
The most important ingredient for therapy, according Rogers, is the 
therapeutic relationship. As stated earlier, Motivational Interviewing’s techniques 
are founded in Rogers’ therapy and his relationship beliefs with clients. He uses 
terms such as unconditional positive regard, empathy and genuineness. Without 
the therapist succeeding in these relationship issues, Rogers’ therapy falls apart. 
Because of his theory behind personality and people seeking self-actualization, if 
the therapy session’s atmosphere does not provide unconditional positive regard 
for the client, then harm will result.  
Transtheoretical Stages of Change Model 
The Transtheoretical Stages of Change Model (Prochaska & DiClemente, 
1982, 1984) described a behavioral change model that can be generally applied 
to explain treatment retention. Their work consists of how and why people 
change on their own as well as with some type of professional assistance. They 
set out to describe a set of predictable stages through which people travel in the 
course of altering addicted behavior: Preconception, Contemplation, 
Determination, Action, and Maintenance. These stages of change, however, are 
not without criticism. In a review of research on the transtheoretical model, Littell 
and Girvin (2002) observed that empirical evidence suggests that the proposed 
stages of change are not discrete, and there is little empirical evidence showing 
sequential transitions through the stages. The researchers proposed that change 
can come about swiftly, often as a result of life events or external pressures, 
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rather than a progression through stages. Nonetheless, the transtheoretical 
model is widely accepted and prescribed due to its useful heuristic view of 
change. Within this approach, motivation can be seen as a client’s present state 
or stage of readiness for change. Several researchers have demonstrated that 
an adaptation of Motivational Interviewing can be effective at influencing stages 
of change including treatment compliance and retention (e.g. Zweben & Zuckoff, 
2002).  
Prochaska and DiClemente (1982, 1984, & 1986) created five criteria for 
the transtheoretical model. First, a sophisticated integration must respect both 
the fundamental diversity and essential unity of psychotherapy systems. Second, 
the model should emphasize empiricism by measurable variables, and be 
validated. The third criterion was to account for how some people recover from 
clinical disorders without the help of professionals. Fourth, the model should 
generalize to a broad range of human problems. And finally, the transtheoretical 
model should encourage psychotherapists to be innovators, rather than simply 
borrowing from other systems (Prochaska, Norcross, & DiClemente, 2002). 
Stages of Change 
Five stages of change have been conceptualized for a variety of problem 
behaviors: Precontemplation, Contemplation, Preparation, Action, and 
Maintenance (Prochaska & Norcross, 2003). One of many reasons for using this 
in an AOD program is its natural connection with the 12 steps of Alcoholics 
Anonymous (AA). While there will be a discussion of these theories later, the 12 
steps of AA (n.d.) are listed below to show how they would fit these stages.  
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Precontemplation is the stage in which people are not intending to take 
action in the foreseeable future, usually measured as the next six months. 
People may be in this stage because they are uninformed or under-informed 
about the consequences of their behaviors. Or they may have tried to change a 
number of times and become demoralized about their ability to change. Both 
groups tend to avoid reading, talking or thinking about their high-risk behaviors. 
They are often characterized in other theories as resistant or unmotivated or as 
not ready for treatment. Traditional therapeutic programs are often not designed 
for such individuals and are not matched to their needs (Prochaska, Norcross, & 
DiClemente, 2002). 
Contemplation is the stage in which people are intending to change in 
the next six months. They are more aware of the pros of changing but are also 
acutely aware of the cons. This balance between the costs and benefits of 
changing can produce profound ambivalence that can keep people stuck in this 
stage for a long time. Those finding themselves in this stage are characterized as 
chronic contemplators or behavioral procrastinators. These people are also not 
ready for traditional action oriented programs and could account for many 
treatment dropouts (Prochaska, Norcross, & DiClemente, 2002). 
Preparation is the stage in which people are intending to take action in 
the immediate future, usually seen as the next month. They have typically taken 
some significant action in the past year. These individuals have a plan of action, 
such as joining a health education class, consulting a counselor, talking to their 
physicians, buying self-help books. or relying on self-change approaches. These 
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are the people who should be recruited for action-oriented smoking cessation, 
weight loss, or exercise programs (Prochaska, Norcross, & DiClemente, 2002). . 
The first three AA steps are undertaken in this stage: 
1.  We admitted we were powerless over alcohol - that our lives had become 
unmanageable. 
2.  We came to believe that a power greater than ourselves could restore us 
to sanity. 
3.  We made a decision to turn our will and our lives over to the care of God 
as we understood Him. 
Action is the stage in which people have made specific overt 
modifications in their life-styles within the past six months. Since action is 
observable, behavior change often has been equated with action. But in the 
Transtheoretical Model, Action is only one of five stages. Not all modifications of 
behavior count as action in this model. People must attain a criterion that 
scientists and professionals agree is sufficient to reduce risks for disease. In 
smoking, for example, the field used to count reduction in the number of 
cigarettes as action, or switching to low tar and nicotine cigarettes. Now the 
consensus is clear--only total abstinence counts. The Action stage is also the 
stage where vigilance against relapse is critical (Prochaska, Norcross, & 
DiClemente, 2002). AA Steps 4 through 9 are to be completed in this stage: 
4.  We made a searching and fearless moral inventory of ourselves. 
5.  We admitted to God, to ourselves, and to another human being the exact 
nature of our wrongs. 
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6.  We sere entirely ready to have God remove all these defects of character. 
7.  We humbly asked Him to remove our shortcomings. 
8.  We made lists of all persons we had harmed and became willing to make 
amends to them all. 
9.  We made direct amends to such people wherever possible, except when 
to do so would injure them or others. 
Maintenance is the stage in which people are working to prevent relapse 
but they do not apply change processes as frequently as do people in action. 
They are less tempted to relapse and increasingly more confident that they can 
continue their change (Prochaska, Norcross, & DiClemente, 2002). AA Steps 10 
– 12 are completed in the Maintenance stage: 
10.  We continued to take personal inventory and when we were wrong 
promptly admitted it. 
11.  We sought though prayer and meditation to improve our conscious contact 
with God as we understood Him, praying only for knowledge of His will for 
us and the power to carry that out. 
12.  We have had a spiritual awakening as the result of these steps; we tried to 
carry this message to alcoholics and to practice these principles in all our affairs. 
Prochaska’s Therapy 
There is an attempt to combine the process of change and the stage. 
Once the stage of change is identified in a client, then the process is applied. 
Prochaska has specific recommendations for the process of change during each 
stage. For example, if a client was in the Precontemplation or Contemplation 
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stage, the therapist would attempt to raise the client’s consciousness and/or 
dramatic relief (Prochaska & Norcross, 2003). Helping the client become more 
aware of the problem and get some emotional relief would move them into the 
next stage. For the Contemplation stage specifically, environmental reevaluation 
and self-reevaluation are used. As clients become more aware of their problems, 
they are more open to reevaluating their values and actions. The Preparation 
stage utilizes self-liberation due to the client’s readiness to change. They need to 
know that they have autonomy to change their lives, which is associated with 
self-efficacy. Action and Maintenance stages use contingency management, 
counter conditioning, and stimulus control (Prochaska & Norcross, 2003).  
The Therapeutic Relationship 
The transtheoretical psychotherapist is viewed not as an expert having all 
of the answers, rather an expert about change. Because some of Prochaska’s 
research studied how people changed without seeking professional services, the 
relationship is based on the assumption that people have the ability and 
capability to change. According to Prochaska, the relationship with the client 
depends on the client’s current stage (Prochaska, Norcross, & DiClemente, 
2002). For example, the relationship with Precontemplators should be that of a 
nurturing parent who allows for independence. Contemplators would create a 
Socratic or teacher position in that the therapist would encourage insight into the 
problem’s conditions. Working with clients in the Preparation stage is like 
coaching a specific game plan. A consultation relationship would be used for the 
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Maintenance stage. This is another reason to use some of the skills of 
motivational interviewing.  
Motivational Interviewing 
Motivational interviewing (Miller & Rollnick, 2002) is a proven practice 
method that has been shown to be as effective as CBT and TSF methods, yet 
much briefer and time limited. For example, Project MATCH researchers (Project 
MATCH Research Group 1993, 1997a, 1997b), in a large and highly respected 
randomly controlled trial (n = 1,726) concluded that an adaptation of motivational 
interviewing, MET, delivered in four 1-hour weekly sessions (Miller & Rollnick, 
1991) was as effective as cognitive behavioral therapy (CBT) (1997a) or twelve-
step facilitation (TSF) methods (1997b) delivered across 12 weekly one-hour 
sessions. Although the adaptation of MI had one-third the number of sessions as 
CBT or 12-Step clients, the number of days using alcohol in the year following 
treatment was substantially the same across all three methods (Glaser et al., 
1999). 
MI provides an approach to explore and resolve ambivalence about 
recovery. As such, MI may offer a common ground on which both AOD treatment 
field and health-care providers may be able to unite and collaborate to ensure 
appropriate care of HIV-infected individuals who are abusing substances. The 
logic behind using MI with this clientele is that replicated clinical trials have 
demonstrated what it is a brief intervention (1 to 4 sessions) that is effective at 
improving substance use outcomes as well as treatment retention and 
compliance (Miller & Rollnick, 2002; Zweban & Zuckoff, 2002). Miller and Rollnick 
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(2002) defined MI as a way of being with people and a set of clinical methods 
that can be taught and learned. MI involves the application of four basic 
principles: (a) expressing empathy, (b) developing discrepancy, (c) rolling with 
resistance, and (d) supporting self-efficacy, thus enhancing intrinsic motivation 
related to initiating some change to a healthier behavior. MI matches specific 
treatment strategies to the client’s is stage of change (Prochaska & DiClemente, 
1982).  
Designing a Motivational Interviewing Intervention 
Denial, defensiveness, and resistance are attributes of substance abusers 
and can be barriers to effective treatment. However, research has not supported 
the conclusion that addicted persons, as a group, have abnormally robust 
defense mechanisms (Miller, 2000). There could be several reasons for this 
belief, the first being that exceptionally difficult clients are elevated to become 
models of usual responses. The term “denial” is often used to describe lack of 
compliance or motivation among substance users, whereas the term “motivation” 
is reserved for concepts like acceptance and surrender (Kilpatrick et al., 1978; 
Nir & Cutler, 1978; Taleff, 1997). According to Miller and Rollnick (1991), clients 
who disagree with clinicians, who refuse to accept clinicians’ diagnoses, and who 
reject treatment recommendations are usually labeled as being in denial.  
A second explanation is that behaviors viewed as normal in ordinary 
individuals are labeled as pathological when observed in addicted populations 
(Orford, 1985). Many people use denial, resistance, arguing, and/or 
rationalization as a common defense mechanism to protect themselves 
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emotionally (Brehm & Brehm, 1981). Aggressive confrontation generally evokes 
outright denial. Motivational Interviewing avoids the pitfalls of direct confrontation 
and not allowing the client to have some selection in treatment goals. MI provides 
a constructive type of therapeutic confrontation thereby helping clients assess 
the reality of their behaviors, reconnect with their personal goals, and recognize 
discrepancies between current behaviors and desired ideals (Ivey et al., 1997). 
Nearly every client coming into the intervention will have some common defense 
mechanisms which will be dealt with by using the principles of MI, i.e. focus on 
client competencies and strengths, refrain from labeling, and create therapeutic 
partnerships for change using empathy rather than authority and power. 
Intervention Development 
Rounsaville, Carroll, and Onken (2001) suggested that intervention 
development begins with selection of an accepted theory or model to guide the 
developers. Although MI has not been used with HIV positive patients or to 
improve retention in an IOP alcohol treatment program, our approach is 
consistent with Rounsaville et al.’s suggestion in that MI already stands as a 
proven practice that can be adapted to treatment retention (Zweben & Zuckoff, 
2002). MI has repeatedly demonstrated success in advancing clients through the 
stages of change in several randomly controlled trials (Burke, Arkowitz, & Dunn, 
2002). More specifically, Miller and Rollnick (1991) defined motivation as “the 
probability that a person will enter into, continue, and adhere to a specific change 
strategy” (p.19), and prescribed MI principles to increase and sustain motivation 
to change. Interventions such as Motivational Interviewing (or adaptations using 
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these principles), have demonstrated promise in increased treatment completion 
and have been shown to be an effective approach for engaging, treating and 
retaining individuals with AOD addictions.  
Zweben and Zuckoff (2002) reviewed 21 studies that assessed treatment 
outcomes and adherence to treatment and found that a majority of the controlled 
studies (12 of 21), using adaptations of motivational interviewing produced 
significant positive effects on treatment adherence including treatment retention. 
As a result, Zweben and Zuckoff (2002) reported that “findings of adherence 
effects in the preponderance of studies leave us cautiously optimistic about 
motivational interviewing as an add-on adherence intervention” (p. 306).  
Miller and Rollnick (1991) contended that motivation is necessary to 
proceed through stages of change, and identified several research-based clinical 
principles and strategies to elicit intrinsic motivation. Walizter, Dermen, and 
Connors (1999) reviewed the MI literature and supported MI’s effectiveness.  
Zweben and Zuckoff (2002) concluded that it is necessary to separate the 
MI intervention process into two distinct motivational problems that must be 
targeted and successfully resolved in order to improve treatment adherence: (a) 
alcohol problem acceptance, and (b) alcohol treatment acceptance (Daley et al 
1998). Whereas problem acceptance is focused on raising intrinsic motivation to 
engage in change strategies related to client’s alcohol dependence, treatment 
acceptance involves facilitating motivation and commitment related to treatment 
adherence.  
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Commitment and Action related to problem acceptance must be in place 
prior to focusing MI on treatment acceptance. Zweben and Zuckoff (2002) noted 
that while there are risks associated with problem acceptance, i.e., 
misperceptions, misunderstanding or uncertainties about the presenting problem, 
treatment acceptance risk factors, i.e. misperception about treatment needs, 
financial or family hardships and stigmas, these can be ameliorated with MI skills. 
Zweben and Zuckoff (2002) provided an exploratory framework for addressing 
adherence, specifically for problem acceptance and treatment acceptance, which 
was used in designing the booster intervention herein.  
The Gap in Knowledge 
 According to SAMHSA (n.d.), women, adolescents, young adults, and 
minorities continue to be under-represented in clinical services because of social, 
cultural, and geographic barriers. This lack of involvement in clinical services 
diminishes access to quality health care, hampers widespread adoption of 
available preventive approaches, limits safe and effective management of HIV 
treatment and associated complications, and jeopardizes the ability of 
researchers to generalize findings to those most in need. As a result, when 
applying for SAMHSA research funds they require a planned attempt at recruiting 
under-represented subjects into the study. 
 By not excluding any subjects in this study for reasons like 
homelessness, criminal justice involvement, psychiatric histories, or any other 
potential problems related to excused subjects for research designs (see Project 
MATCH Research Group 1997a), as well as purposefully including HIV-infected 
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individuals, this dissertation will test the effects of an intervention with individuals 
who seldom have the opportunity to be involved in research: The primary 
scientific gap in knowledge is the specific utilization of a Motivational Interviewing 
intervention with AOD addicts who are also HIV/AIDS positive. While MI has 
been studied using a variety of subjects in multiple settings, i.e. medication 
compliance (Adamian et al., 2004; Parsons et al., 2005; Safren et al., 2001), and 
HIV risk reduction (Harding et al., 2001; Parsons, 2005), evidence-based 









In September 2002, the Volunteers of America’s (VOA) intensive 
outpatient (IOP) clinic in Louisville, KY received funding under SAMHSA to 
enhance its addiction services for HIV-infected and high-risk populations—the 
gap in knowledge previously identified. The new funding allowed VOA’s IOP 
program to expand its existing treatment services and treatment outcome 
research infrastructure. The program increased its original staff of one certified 
alcohol and drug counselor (CADC) and one case manager to two additional 
CADCs, two case managers, two associate counselors, and a child advocate to 
monitor the children while their parents/guardians received treatment. The IOP 
program is funded through 2007. As part of their IOP evaluation, VOA personnel, 
as well as University of Louisville evaluators, obtained base line, 6-month and 
12-month data with an 80% follow up requirement. Infrastructure and protocols 
were in place for obtaining consent, substance abuse and safer sex outcome 
measures, location and followup at six months after intake, and data entry. 
This chapter is organized to first bring the reader into (a) the context of the 
dissertation study. A preliminary study had just been completed that is briefly 
described. Then (b) a purpose statement is provided, followed by the (c) 
research design section that includes the consent procedure, inclusion criteria, 
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and how clients were assigned to the treatment and comparison groups. The (d) 
protocol includes subsections for the comparison and treatment groups, and the 
operationalization of all variables. The research design section closes with a brief 
review of analyses conducted, and limitations of the study.  
Retention in IOP Prior to Current Study 
During the first year of the Volunteers of America’s intensive outpatient 
clinic, the vast majority of HIV-infected clients who entered the IOP program 
dropped out of treatment well before completing, and the number of sessions 
attended was low. The program under study was designed for 26 weeks of 
primary treatment followed by approximately 26 weeks of aftercare, and includes 
a total of approximately 130 treatment sessions prior to completion. The IOP 
clients attend five days a week, Monday through Friday, approximately four hours 
per day. The total number of male clients entering the program the first year 
(2003) was 48, with 27 of those being African-Americans and 21 White. Thirty-
seven were HIV-infected at the time of admission while 11 reported not being 
HIV-infected. Means indicate that HIV-infected men dropped out of IOP after only 
13.8 days (SD = 18.74) compared to non-infected men dropping out after 19.9 
days (SD = 27.16). Although a notable difference was observed between infected 
and non-infected clients, the difference was not statistically significant (t (46) = -
.859, p = .395).  
A preliminary study at an intensive outpatient substance abuse treatment 
program for those infected with HIV and served by VOA of Kentucky and 
Tennessee’s Intensive Outpatient Clinic, yielded high rates of treatment dropout 
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Although many agreed to and entered treatment, most abandoned treatment 
soon afterwards, which prompted this study. It is hypothesized that up to five 
additional “booster” sessions of an adaptation of motivation interviewing along 
with intensive outpatient alcohol and drug treatment services will increase days in 
treatment (retention and completion) among these dually diagnosed (substance 
dependence and HIV-infected) individuals who were active in the intensive 
outpatient treatment program within VOA in Louisville, KY. This dissertation was 
a pilot study with posttest only comparison groups and sequential assignment to 
treatment and comparison groups. An adjustment was made to balance the 
groups in terms of HIV positive clients—a deviation from strict random 
assignment. The intervention in the treatment group (n = 50) consisted of IOP + 
up to five additional MI booster sessions, and clients in the comparison group (n 
= 56). 
Purpose Statement 
The purpose of this study was to test the effects of up to five add on 
booster MI sessions (an adaptation of MI intervention, Miller & Rollnick, 2002) 
during the first two weeks of treatment—the time when most dropouts occur. The 
object is to learn whether these additional MI sessions will help to increase rates 
of treatment retention and completion in an intensive outpatient addiction 
program with alcohol and other drug (AOD) addicted as well as individuals who 
are also HIV-infected AOD. This research built upon existing research 
infrastructure, and expanded an ongoing treatment longitudinal outcome study 
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(sponsored by SAMHSA-Center for Substance Abuse Treatment [CSAT] TI03-
008) of individuals assessed as high risk for HIV or HIV-infections. 
The following steps have been completed as part of the CSAT study that 
has been underway since late 2003: (a) outreach workers have been trained in 
MI and have been engaged in regular weekly supervision since October, 2003, 
and (b) basic demographics and personal information to describe the sample and 
treatment outcome measures were collected since the beginning of the study. 
The dissertation represents the next step in intervention development described 
by Rounsaville et al.,(2001), a stage 1b, a small, randomly controlled pilot study 
of 15 to 30 subjects per group, treatment and comparison. 
Research Design 
The research design is posttest only comparison groups:       X   01 
                _ _ _ _ _ _ _  
                                                                                             01 
where X represents the treatment of up to five additional (booster) MI sessions 
within the first two weeks of IOP sessions for the treatment group of alcohol 
dependent people who could also be HIV-infected, and 01 represents posttests, 
or outcome measures (Campbell & Stanley, 1963). This was an intent to treat 
study, meaning that subjects who were assigned to the treatment group were 
analyzed, even if they did not follow through to attend any of the MI sessions.  
The comparison group consisted of alcohol dependent people and who could 
also be HIV-infected, and who had the same posttests but not the intervention 
(X), the additional MI booster sessions. All clients were AOD dependent, 
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received the intensive outpatient intervention, and were invited to participate in 
the study (Appendix A). 
Consent 
The existing consent form (required by SAMSHA-CSAT) and the 
University of Louisville’s Human Subjects Protection Program Office’s 
Institutional Review Board (IRB) was amended to reflect the up to five additional 
MI sessions (Appendix B). Subjects were either assigned to the additional 
motivational counseling treatment condition or the comparison group consisting 
of the standard IOP services. 
Inclusion Criteria 
Subjects (a) were 18 or older, (b) were diagnosed alcohol dependent 
according to supporting documentation from referral sources or via the Addiction 
Severity Index (ASI; Fureman, Parikh, Bragg, & McLellan, 1990; McLellan, 
Lubrosky, Cacciola, & Griffith, 1985), (c) could read and understand English 
sufficiently to complete informed consents and data collection forms, and (d) 
agreed to engage in intervention activities in the VOA’s IOP program. 
Assignment to Groups 
Participants were assigned to treatment and comparison groups in a 
sequential manner. The first eligible person was assigned to the treatment group, 
the next eligible participant to the comparison group, thus altering until sample 
size was achieved. Only the MI counselor who provided the MI booster 
intervention was knowledgeable of the assignment. The client and IOP staff were 
masked or blind to the assignment, which could have resulted in an unintended 
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intervention or treatment diffusion that could have affected the results of the 
study.  
Protocol 
The protocol for the comparison group is first described, then the 
procedures for the treatment group. All subjects received the IOP services as 
described here for the comparison group. 
Comparison Group and IOP for all Subjects 
The comparison group, those receiving the standard treatment of the 
VOA’s IOP program services, received all usual and customary services 
rendered by the VOA program. The only difference between the treatment and 
comparison groups was the additional MI sessions. 
Treatment was provided by the VOA IOP program and consisted of 
weekly individual and group counseling sessions five days a week over a six-
month period. All clients admitted to the VOA IOP program adhere to a rigorous 
weekly schedule consisting of 12-step educational sessions, drug refusal skills, 
life skills, treatment planning, and group therapy. Group therapy is largely 
focused on engaging clients in twelve-step recovery using a highly structured 
twelve-step facilitation method that is fundamentally grounded in the AA 
literature. IOP clients also must attend a minimum number of Alcoholics 
Anonymous meetings during the course of treatment (usually 5 meetings 
weekly). All counselors are certified alcohol and drug counselors (CADC) or 
within a year of obtaining certification. 
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Treatment Group 
Once subjects were admitted to the program and volunteered to be in the 
study the MI counselor was notified. An attempt was made to schedule the first 
intervention session for the treatment group the following day, which would have 
been the first full day of IOP. MI sessions were available only to those in the 
treatment group and were conducted between regularly scheduled IOP 
counseling or educational meetings. At the beginning of the first MI session 
subjects were asked if they understood the consent form and whether they had 
any questions. Subjects in the treatment group were reminded that they were 
selected to receive additional counseling sessions in order to improve treatment 
retention and completion. 
The MI counselor placed less prominence on a manualized approach to 
MI, rather following Miller and Rollnick’s (2002) suggestion of remaining in the 
spirit of motivational Interviewing. Miller and Rollnick concluded after several 
years of experience, that “. . . we have found ourselves placing less emphasis on 
techniques of motivational interviewing and ever greater emphasis on the 
fundamental spirit that underlies it” (p. 33). Motivational interviewing consists of 
two phases. Phase 1 focuses on identifying and strengthening clients’ existing 
motivation for change, and Phase 2 seeks to consolidate clients’ commitments to 
change (Miller & Rollnick, 1998). 
Each session’s fundamental framework consisted of the counselor 
focusing on Miller and Rollnick’s (2002) suggestion of client collaboration, 
evocation, and autonomy. The counselor avoided an authoritarian relationship, 
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instead, communicating in a partner-like relationship. The session also steers 
clear of any attempt to insert insight or education, but elicits clients’ intrinsic 
motivation. The final key component of remaining in the spirit of MI is the 
awareness that change is ultimately the responsibility of the client (Miller & 
Rollnick, 2002). 
Because sessions were addressing treatment adherence, the counselor, 
while remaining in the spirit of MI, followed Zweben and Zuckoff’s (2002) 
strategies of treatment nonadherence (Appendix C). The counselor delivering the 
intervention was a Ph.D. psychologist who has received extensive training and 
supervision in motivational interviewing and has been using MI for 7 years. 
Operationalization of Variables 
The main dependent variable is the number of days in treatment. All data 
were collected by the administrative assistant—the demographics in the intake 
process (four items) and days in treatment when clients either completed the 
program or ceased to return. The researcher entered the data into the Statistical 
Package for the Social Sciences (SPSS), and then rechecked the entries. 
The following section describes variables that encompass demographic 
variables included age, gender, race, and HIV/AIDS status. Subjects’ ages were 
provided in years at the date of admission. There are two categories of gender, 
male and female. Four categories were used to describe the race of participants: 
African-American, Caucasian, Native American and Hispanic. HIV/AIDS status 
consisted of self-reported HIV/AIDS negative and positive. The number of MI 
sessions received by the treatment group was the actual number of MI sessions 
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attended by each subject (0 to 5). Operationalization of the two primary 
dependent variables consisted of the actual number of IOP sessions attended (0 
to 119 over six months) and treatment completion (0 = No; 1 = Yes, completed 
with staff approval).   
Supplemental variables were also used to assess the MI intervention dose 
levels. Subjects in the treatment group could receive up to five MI sessions 
during the first two weeks. These sessions (doses) were dichotomized as below 
and above the median number of MI sessions (2) which resulted in 0 to 2 MI 
sessions = Low dose (recoded as 0), and 3 to 5 sessions = High dose (recoded 
as 1). 
A counselor’s perception of severity was determined by whether subjects 
were excluded from or included in the Government’s Performance and Results 
Act (GRPA). Programs receiving funds from SAMSHA-CSAT are required to 
enter client data into the GPRA system at three points in time (baseline, and 6 
and 12 months post baseline). Once subjects are entered into the GPRA system, 
an 80% followup rate is mandated. Those subjects evaluated at admission to be 
high risk to locate at followup are not entered into the GPRA system, thereby 
indicating subject instability. In other words, more severe is seen as those who 
are more unstable and least likely to be found for following up, as required by 
GPRA. Factors considered by intake counselors included poor health, recently 
hospitalized, dying, homeless or in shelters, left town, in jail or running from 
authorities, and no evidence of collateral contacts. A dichotomous variable (0 = 
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No; 1 = Yes, Severe) was created to reflect participants’ entrance into GPRA. All 
variables are operationalized in Table 2. 
Table 2 
Variable Categories  
 Variable Operationalization of  
Independent Variables 
Data Level 
1 Age Actual age in years Ratio 
2 Gender 0 = Male                                                 
1 = Female                                             
Nominal 
3 Race 1 = African American                              
2 = Caucasian                                        
3 = Native American                               
4 = Hispanic 
Nominal 
4 HIV Status 0 = HIV-Negative                                    
1 = HIV-Positive 
Nominal 
5 Number of MI 
Sessions 
Actual number of sessions Ratio 
Primary Dependent Variables  
6 Number of IOP 
sessions attended 
Actual number of IOP sessions 
attended 
Ratio 
7 Completed IOP 0 = Did not complete                              
1 = Completed 
Nominal 
Supplemental Variables  
8 MI Dose (number 
of MI sessions) 
0 = Below Median 
1 = Above median 
Nominal 
9 Client Severity 0 = Entered into GPRA 




Data analysis began with examining sample demographics, plots and 
histograms of key variables. Tests of between group differences were conducted 
to assess whether groups were comparable (chi square for dichotomous and 
categorical variables, t-test for continuous variables). The characteristics of 
subjects who were HIV/AIDS positive were described and key variables 
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analyzed. Three additional supplemental analyses were conducted to attempt to 






This dissertation tested the effects of a motivational intervention on 
treatment retention of 106 clients who were addicted to alcohol and other drugs 
(AOD) and enrolled in an intensive outpatient treatment program. For the 
purposes of this study, retention was operationalized as both a continuous 
variable (number of sessions attended prior to discharge from the program), and 
a dichotomous variable representing completion status (did or did not complete 
the treatment program). Description of the sample is followed by reporting results 
of testing two hypotheses, first among the entire sample (n = 106) and then 
among those who were HIV positive (n = 28). 
Sample Description 
Table 3 describes the sample in terms of age, gender, race and HIV 
status by comparison group (n = 56), treatment group (n = 50) and in total (n = 
106). Fifty subjects were sequentially assigned to the treatment condition, and 56 
to the comparison group. Subjects’ mean age was 35 years with a range of 19 to 
63 years. The sample was approximately evenly split in terms of gender with 
51.9% women. The sample was racially balanced with approximately 47% of the 
sample reporting that they were African American, 49% white, and 4% Hispanic 
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or Native American. The vast majority of the sample were HIV negative (73%), 
and 26% reported that they were HIV positive.  
No significant differences were observed in a comparison of the groups 
using t-tests on age and chi-square on race, gender, and HIV status, suggesting 
that the groups were similar. As Table 3 indicates, the average age of both 
groups was approximately 35 years. Of the 55 females entering the study, 
approximately half, 26, were in the treatment group. Twenty-four of the 51 males 
in the study were assigned to the treatment group. The racial mix and HIV/AIDS 
status were also equally distributed. None of the demographic differences 
resulted in statistically significant findings. 
Table 3 
Baseline Characteristics of Respondents (n = 106) 
 
 Treatment (n = 50)
Mean (SD) 
Comparison (n = 56) 
Mean (SD) 
Total (n = 106) 
Age          
 34.7 (9.4) 34.1 (10.1) 34.4 (9.7) 
 19-59 (range) 19-63 (range) 19-63 (range) 
  n (%) n (%) Total 
Gender 
     Male 24 (48.0%) 27 (48.2%) 51 (48.1%) 
     Female 26 (52.0%) 29 (51.8%) 55 (51.9%) 
Race 
     African-American 24 (48.0%) 26 (46.4%) 47 (47.2%) 
     Caucasian 24 (48.0%) 28 (50.0%) 52 (49.1%) 
     Hispanic 1  (2.0%) 1  (1.8%) 2  (1.9%) 
    Native American 1  (2.0%) 1  (1.8%) 2  (1.9%) 
HIV Status 
     Positive 13 (26.0%) 15 (26.8%) 28 (26.4%) 
     Negative 37 (74.0%) 41 (73.2%) 78 (73.6%) 
Note: None of the between group differences were significant at p .05. 
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Hypothesis Testing 
Hypothesis 1: Subjects in the treatment group (IOP + up to 5 MI 
sessions in the first two weeks) will attend significantly more IOP sessions 
than those in the comparison group. 
An independent sample t-test was conducted to test Hypothesis 1. In the 
total sample the mean number of days in treatment was 35 (SD = 30) with a 
range from 1 to 120 days (Figure 2). Forty-four subjects attended less than 20 
days, a time in which most treatment dropout occurs (Anglin & Hser, 1990).  
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Figure 2. Histogram of attendance for total sample. 
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Figure 3 is a histogram of attendance in days for the treatment group. The 
mean number of days attended for the treatment group spent was 33 (SD = 27) 
days. The distribution is positively skewed with half of the subjects in the 
treatment group dropping out within the first 20 days of treatment  
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N = 50
 
Figure 3. Histogram of attendance for treatment group. 
 
Figure 4 is a histogram representing the comparison groups’ number of 
days in treatment. The comparison group had an average of 37 days in treatment 
(SD = 32). While positively skewed this distribution depicts a large proportion of 
people who dropped out within the first 20 days, and then a more normally 
distributed group of individuals who remained beyond 20 days. 
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Figure 4. Histogram of attendance for the comparison group. 
 
Table 4 reports the sample’s mean number of days in treatment for both 
conditions and the total sample. The results of the 2-tailed t-test indicated that 
there was no significant difference between the mean number of days in 
treatment between groups (t = .721, df = 104, p = .472, n = 106). Therefore, H1, 
that subjects in the IOP program who were assigned to the treatment group 
would have increased retention as measured by days in treatment, is rejected. A 
power analysis with t-test yielded a medium effect size (0.5) (alpha = 0.05; delta 
= 2.5698; critical t(104) = 1.6596; power = 0.8181). While not statistically 
significant, the means varied in the opposite direction of what was hypothesized, 
with the comparison group remaining in the program longer than the treatment 
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group (mean of 37.3 days for the comparison group compared to 33 days for the 
treatment group, Table 4).  
Table 4 
Number of Days in Treatment 
 
 Treatment (n = 50) Comparison (n = 56) Total (n = 106) 
Mean (SD) 33 (27) 37.3 (32) 35.3 (30) 
 
Hypothesis 2: A higher percentage of AOD addicted subjects in the 
treatment group (IOP + up to 5 added on MI sessions in the first two weeks) 
will complete treatment than those in the comparison group. 
Overall, 75 of the subjects (70.8%) dropped out of the program before 
completing, including 72% of the comparison group and 69% of the treatment 
groups. Inversely, only 28% and slightly more than 30%, of the comparison and 
treatment groups, respectively, completed treatment (Table 5). Chi-square tests 
indicate that the intervention did not play a significant role in treatment 
completion (chi-Square = .082, df = 1, p .774, n = 106) resulting in the rejection of 
the hypothesis. The results are in the opposite direction of the hypothesis. The 
power for f-test on Means is low, ANOVA with medium effect size (0.25) (alpha = 
0.05; power = 0.7224; critical F (1,104) = 3.9324; Lambda = 6.625; Table 5).  
Retention and Completion by HIV Status 
As stated earlier, part of the overall purpose of the study was to test the 
intervention on a sample representative of the treatment program, as well as 
53 
Table 5 
Dropout and Completion by Treatment and Comparison Groups 
 Treatment Comparison Total 
% Dropout 34 (69.4%) 41 (71.9%) 75 (70.8%)
% Completed 15 (30.6%) 16 (28.1%) 31 (29.2%)
Total 49 (100.0%) 57 (100.0%) 106 (100.0%)
Chi-Square = .082, df = 1, p. 774 
 
those who were HIV-infected. This is consistent with Rounsaville, Carroll, and 
Onken’s (2001) methods of intervention development that contend that small 
samples (n = 30 to 60) Stage 1b1 pilot studies are necessary as an initial step in 
intervention development even though statistical power is admittedly limited. 
HIV/AIDS Sample Description 
Table 6 reports demographics of subjects self-identifying as being HIV-
infected and entering into the IOP clinic—only those who self-identified in this 
manner are included in this section. Thirteen HIV/AIDS subjects were assigned 
to the treatment group, and 15 to the comparison group. On average, subjects in 
this HIV/AIDS sub-sample of 28 were approximately 37 years of age (SD = 9.1). 
The majority of the HIV/AIDS subjects were men (n = 19, 67.9%). The total HIV-
infected sample was disproportionately made up of minorities; approximately 
71% of subjects in this sub-sample were African American and 28% were White. 
Nine of the total 19 males in the HIV/AIDS sub-sample were assigned to  
                                                 
1  Stage 1a: Therapy Development & Manual Writing  
Stage 1b: Pilot trials 




Baseline Characteristics of HIV/AIDS Positive Respondents 
 
 Treatment (n = 13)
Mean (SD) 
Comparison (n = 15) 
M(SD) 
Total (n = 28)
Age          
  38.3 (9.6) 35.3 (8.6) 36.7 (9.1) 
Gender 
     Male 9 (69.2%) 10 (66.7%) 19 (67.9%) 
     Female 4 (30.8%) 5 (33.3%) 9 (32.1%) 
    
Race 
     African-American 8 (61.5%) 12 (80.0%) 20 (71.4%) 
     Caucasian 5 (38.5%) 3 (20.0%) 8 (28.6%) 
Note: None of the between group differences were significant at the p .05 level 
 
the treatment group. The racial mix in the two groups was similarly distributed. 
None of the between group differences were significant, suggesting that the 
groups were comparable. 
HIV/AIDS Status and Hypothesis 1 (Days in Treatment) 
There is no significant difference between the treatment and comparison 
groups in the mean number of days in treatment of those who were HIV/AIDS 
positive. However, setting aside the treatment and comparison groups, non-
HIV/AIDS subjects have a significantly higher mean number of days in treatment 
than HIV/AIDS positive clients (t = 3.022, df = 104, p = .003, n = 106). Figure 5 
shows the mean number of days in IOP care by treatment/comparison group and 
HIV/AIDS status/non. Figure 5 shows that AOD clients who are HIV/AIDS 
negative are in treatment the longest, 43 days for the comparison group and 37 


































Figure 5. Mean number of days in treatment by group and HIV/AIDS status 
(p .024) 
 
HIV/AIDS Status and Hypothesis 2 (Treatment Completion) 
Of the 28 HIV/AIDS positive subjects, five (18%) completed treatment, 2 
in the treatment group and 3 in the comparison group (chi-Square = 2.385, df = 
1, p = .123, n = 28). Due to the low number of HIV-infected subjects entering the 
program, data analysis was limited. Analyzing the effects of the MI booster 
sessions attended on completing treatment using cross tabulation resulted in too 
many cells with expected frequencies less than five, thereby not generating a 
valid statistical result. However, the counts and percentages are in Table 7. 
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Table 7 
Treatment Completion by HIV/AIDS Status 
 Treatment Comparison Total 
Dropped Out 11  84.6% 12  80.0% 23  82.1% 
Completed 2 15.4% 3  20.0% 5  17.9% 
Total 13  100.0% 15  100.0% 28  100.0% 
 
Supplemental Analyses 
Three additional supplemental analyses were conducted to attempt to 
explain the results of the study. In these analyses, only the number of IOP 
sessions dependent variable was used, since completion status is a function of 
the number of IOP sessions attended. In other words, number of days in 
treatment dictates completion, making it a circular exercise, or redundant.  
The first supplemental analysis was conducted to investigate the 
influence of 10 subjects in the treatment condition (who included to satisfy an 
intent to treat test, in bold in Table 8), and who received no MI sessions on the 
outcome, the number of IOP sessions.2 Table 8 shows the mean, median, mode 
and standard deviation of MI sessions provided to the treatment group, along 
with frequency of sessions attended. 
The median number of sessions received by those in the treatment group 
(n = 50) was 2. In order to control for the possible effect of not attending any MI 
sessions, the 10 subjects who received no MI sessions were excluded from the 
treatment group in this analysis only. Table 9 shows the descriptive statistics for  
                                                 
2  Ten subjects assigned to the treatment condition left treatment prior to meeting with the 
MI counselor, thus they received no MI sessions. As stated earlier, these subjects were 
included in the original analysis of both hypotheses. 
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Table 8 
Number and Frequencies of Motivational Interviewing Sessions 
Mean Median Mode Standard 
Deviation 
2.1 2  3 1.5 
       
Motivational Interviewing Sessions Frequency %  
0 10 20  
1 9 18  
2 9 18  
3 12 24  
4 8 16  
5 2 4  
 
Table 9 
Descriptive Statistics of Total Sample and After Exclusion 










Age at Admission 
Total Sample 106 34.4 28 19 - 63 9.7 
Treatment 50 34.7 19 19 - 59 9.4 
Comparison 56 34.1 41 19 - 63 10.1 
Treatment after 
Exclusion 
40 34.6 19 19 - 59 9.5 
Gender   Female Male 
Total Sample  55  51.9% 51 48.1% 
Treatment 26 52.0% 24 48.0% 
Comparison 29 51.8% 27 48.2% 
Treatment after Exclusion
 
19 47.5% 21 52.5% 
Race Black White NAI3 Hispanic 
Total Sample 47 47.2%  52 49.1%  2 1.9% 2 1.9%
Treatment 24 48.0%  24 48.0% 1 2.0% 1 2.0%
Comparison 26 46.4%  28 50.0%  1 1.8% 1 1.8%
Treatment after 
Exclusion 
20 50.0% 18 45.0%  1 2.5% 1 2.5%
HIV/AIDS Status  Negative Positive 
Total Sample 78 73.6% 28 26.4% 
Treatment 37 74.0% 13 26.0% 
Comparison 41 73.2% 15 26.8% 
Treatment after Exclusion 28 70.0% 12 30.0% 
 
                                                 
3  Native American Indian 
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the truncated treatment group (data for the full treatment group are also 
presented for comparison purposes) and the comparison group. 
Results of a t-test indicated that there was no significant difference 
between the truncated treatment and comparison groups in mean number of IOP 
sessions attended (t = .178, df, 94, p = .859). Thus the inclusion or exclusion of 
the 10 subjects in the treatment group who received no MI sessions did not 
significantly influence the number of IOP sessions attended.  
A second supplemental analysis included both univariate and multivariate 
analyses to better understand the differences and similarities in the correlates 
and predictors of the number of IOP sessions attended. First, correlations among 
demographic variables, independent variables, additional measures, and 
dependent variables (Table 2) were analyzed. Variables that were significantly 
related to the primary outcome, number of IOP sessions attended, were retained 
for inclusion in the multivariate analyses. A multiple regression was conducted to 
identify those variables that accounted for a significant proportion of the variance 
in the outcome. In the first block, any variable, with the exception of the primary 
independent variable (treatment vs. comparison group), that was found to be 
significantly related to the outcome in the bivariate analysis was entered. In the 
second block, the treatment condition was entered. Table 10 presents the 
correlation matrix of age, gender, race, HIV/AIDS status, number of MI sessions, 
number of IOP sessions, completion, MI dose, and client severity. 
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Examination of Table 10 indicates that two variables were significantly 
related to the outcome (number of IOP sessions): HIV/AIDS status and client 
severity. While the relationship between number of MI sessions and number of 
IOP sessions did not reach the conventional level of significance, it was 
approaching significance (p = .065).  
 
Table 10 
Correlation Matrix  
  1 2 3 4 5 6 7 8 9 
1. Age   .074 .087 -.016 -.011 .005 .031 .043 -.135
2. Gender .074   -.065 *-.237 .145 -.066 .079 .206 *.204





**-.286  -.040 **-.284 -.150 -.066 -.091
5. # of MI 
sessions 
-.011 .145 .277 -.040  .263 .103 **.862 .085
6. # of IOP 
sessions 
.005 -.066 *.221 **-.284 .263  **.633 .122 **.453
7. Completion .031 .079 -.004 -.150 .103 **.633   -.053 **.258
8. MI Dose .043 .206 *.332 -.066 **.862 .122 -.053  .020
9. Client 
Severity 
-.135 *.204 .131 -.091 .085 **.453 **.258 .020  
Pearson’s correlations: * = Significant at p<.05; ** Significant at p <.01 (2-tailed). 
 
Three variables were retained for inclusion in the multivariate model:  
HIV/AIDS status, client severity, and number of MI sessions attended. Although 
the number of MI sessions failed to yield a significant relationship with the 
primary outcome, it was retained in the multivariate analysis because it 
approached significance and was a major component of both hypotheses. Table 
11 shows the unstandardized regression coefficients (b), standard errors (SE), 
and standardized beta for the regression model. The linear combination of 
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variables in the multivariate model accounted for 32% of the variance in the 
number of IOP sessions attended. Examination of Table 12 indicates that client 
severity and HIV status were significant predictors of the number of IOP sessions 
attended. Given the findings in the bivariate analysis, it was not surprising that 
the number of MI sessions attended was not a significant predictor of the 
outcome, number of IOP sessions attended.  
The fact that the 2nd block is not significant indicates that the severity and 
HIV/AIDS status were significant at predicting number of IOP sessions (r2 change 
= .315, f= 10.801, df= 47, p, = .000). However, even when controlling for effects 
of severity and HIV/AIDS status, MI group involvement was not significant at 
predicting number IOP sessions (r2 change = .042, f = 3.042, df = 46, p. =.088) 
 
Table 11  
Unstandardized Regression Coefficients 
Dependant Variable = Number of IOP Sessions Attended 
Model 1 
Variable Beta Coefficient Std. Error 
Client Severity   27.995** 6.882 
HIV Status -24.107** 7.743 
      
Model 2 
Variable (excluded) Beta Coefficient Std. Error 
MI Sessions 3.819 2.19 




Relationship between HIV/AIDS & Client Severity 
  HIV/AIDS Negative HIV/AIDS Positive Total 
Severe 31 (39.7%) 14 (50.0%) 45 (42.5%)
Not Severe 47 (60.3%) 14 (50.0%) 61 (57.5%)
Total 78 (100.0%) 28 (100.0%) 106 (100.0%)
 
The third and final supplemental analysis was a chi-square testing the 
relationship between HIV/AIDS status and client severity (Table 12). This 
analysis was done to determine if the most severe clients were those who were 
HIV/AIDS positive. Overall, 45 of the subjects (42.5%) were severe, including 
39.7% of the HIV/AIDS negative and 50% HIV/AIDS positive. Those subjects not 
severe totaled 61 (57.5%) with 60.3% HIV/AIDS negative and 50% HIV/AIDS 
positive. This final supplemental analysis resulted in a non-significant relationship 
(chi-square = .887, df = 1, p .379, n = 106). 
Summary of Results 
Neither of the two hypotheses were supported. Contrary to the MI 
literature, an average of two MI booster sessions did not result in subjects in the 
treatment group attending more IOP sessions or completing treatment for 
addiction to alcohol and other drugs. Supplemental analyses, however, showed a 
statistically significant relationship between HIV/AIDS status, severity (or the 
degree to which clients appeared to be sufficiently stable to be located for 
followup assessments), and days in IOP treatment: HIV/AIDS positive clients 





DISCUSSION AND IMPLICATIONS 
The results of this study suggest that additional Motivational Interviewing 
sessions within the first two weeks of treatment do not increase the number of 
days in intensive outpatient treatment for VOA’s clients addicted to alcohol and 
other drugs, some of whom are also HIV/AIDS positive. Neither is there a 
statistically significant relationship between having/not having additional 
Motivational Interviewing sessions in the first two weeks of treatment and 
completing treatment. The first reaction to this news is to search for flaws in the 
research design, and the most prominent error was this designer’s 
misunderstanding of the exact nature of clients’ problems. For example, this 
researcher underestimated the magnitude of the impact of myriad negative 
factors in clients’ histories, relationships, and social environments that have 
resulted in their current predicaments: addicted to alcohol and other drugs, and in 
26% of the sample, positive for HIV/AIDS. In hindsight, how could a few 
motivational sessions overcome lifetimes of negative influences?  
Implications of Theoretical Perspectives 
This final chapter begins with examining the implications of this study 
relating to the theoretical perspectives that provided guidance. Some 
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weaknesses and oversights will be discussed along with study design flaws. It 
concludes with knowledge gained and recommendations for future research. 
Looking back at the theoretical perspectives of Rogers and Prochaska 
and how those perspectives informed and guided this study, is important for the 
future direction of researching this specific population. From Rogers’ perspective 
we are born with a positive valuing process that enhances and maintains those 
positive things in our lives, and devalue negative experiences that stagnate our 
growth potential. Rogers (1951, 1961, & 1980) concluded that our worlds are of 
our own making (our reality) and that in order for someone else to understand 
our real realities they must attempt to place themselves in our frames of 
reference. Once we can truly understand ourselves, we seek positive regard for 
that self.  
Rogers’ (1951, 1961, & 1980) goal in treatment is basically what should 
happen during treatment. The therapist should be empathic always with an eye 
toward valuing the client. As stated earlier, this provides a venue and justification 
for intervening with the Motivational Interviewing approach. Successfully applying 
MI during a counseling session is to be empathic with the client, or as Miller and 
Rollick (2002) claim, MI is a way of being with people.  
Focusing on what happens during the therapy process is vital. However, 
what was discounted during this study (as well as Rogers’ theoretical 
underpinning [1951, 1961, & 1980]) was the limited resources the client brings to 
therapy sessions. This theoretical perspective assumes that the client has sound 
personal agency outside of the therapeutic arena, and that the identified problem  
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at hand can be the main focus during its treatment. Unfortunately, for many 
individuals entering into treatment, the power of during treatment therapeutic 
empathy cannot revise the rule of 24/7 poverty. Can a therapist meet the level of 
being empathic while working under the assumption that the lack of motivation or 
poor personal agency is the cause, and targeting it can be the cure? 
Methodological Limitations 
There was a departure from sequential random sampling. Because those 
who entered the program being addicted to alcohol and other drugs as well as 
suffering from HIV/AIDS made up a much smaller segment, one adjustment was 
made to better balance experimental and control groups. After several months of 
sequential assignment and close to the end of the study, a decision was made to 
place the next HIV/AIDS subject into the comparison group in order to balance 
out the two groups. This adjustment violated assumptions of random sampling. 
Another limitation was not monitoring the intervention for fidelity. While the MI 
counselor was well seasoned, trained, and credentialed, it is not known whether 
the proposed protocols were followed as none of the sessions were observed or 
taped. 
The sample and statistical power are also small. However, Rounsaville et 
al. (2001) noted that small pilot studies of 15 to 30 subjects per group are 
necessary in Stage 1b of intervention development research. The sample is a 
single site community of people receiving addiction treatment; therefore, the 
results cannot be generalized to other populations.  
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Another study limitation was not obtaining baseline data related to 
possible factors which were contrary to treating addiction at the most minimum 
level of care--outpatient. Although randomization would seemingly have solved 
baseline differences, it cannot be assumed that clients living in poverty are 
outliers and would be equally distributed. The majority of subjects in the study 
could have enormous external forces working against remaining in minimal care. 
This could explain the 70% termination from treatment before completion. To 
think that a few empathic Motivational Interviewing sessions during the first two 
weeks of IOP treatment could overpower the awesome forces this population 
deals with on a daily basis was blatant naivety.  
Based on working in the Volunteers of America system for about 10 years, 
it is clear that the most common characteristic of VOA clients is that they live in 
poverty which is commonly overlooked and misunderstood. In addition, a majority 
of clients entering this VOA program do not have stable living arrangements or 
even the most basic necessities. They have histories of chronic medical 
dilemmas (e.g. diabetes, HIV/AIDS, Tuberculosis, and Hepatitis) along with the 
lack any health care services. While they may live within walking distance of 
some of the best health care facilities in the world, they are denied that care 
because they have no jobs and little/no income or insurance. They also present 
with multiple addictions beginning early in life and developing into chronic 
conditions that are much more difficult to treat. Involvement in the criminal justice 
system is something that is simply expected. Due to the intergenerational effects 
of poverty, this population is also deficient in any social or family support 
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stemming from the intergenerational effects of poverty. Having entered into 
addiction treatment services, all of those co-evolving problems continue without 
regard to the best intentions of the empathic Motivational Interviewing therapist.  
The individual suffering from these problems could be considered to be 
pauper type addicts. This is not an attempt to coin a clever label, but a 
suggestion for a new way of thinking and treating a unique person who requires 
specific services. Many times this cohort is labeled as homeless. But that does 
not get to the marrow of what is occurring in their lives. The homeless identity 
also sends a message to the professional helper about which problem to deal 
with first. The pauper type addict’s assessed problems cannot be hierarchically 
ranked and dealt with one at a time. Their problems are like Aspens, where 
people like to vacation—the trees bloom together because they are connected by 
their roots. So must the problems of such clients be addressed together—
because they are connected by their roots. 
This study was guided by the Transtheoretical Stages of Change model 
(Prochaska & DiClemente, 1983, 1984). Unfortunately, when treating the pauper 
type addict for addiction, this model seems to also overlook the unique, co-
evolving problems of the sufferer. The stages-of-change-model consists of how 
and why people change on their own as well as with some type of professional 
assistance. The model describes a set of predictable stages through which 
people travel in the course of altering addicted behavior: Preconception, 
Contemplation, Determination, Action, and Maintenance. The groundwork for this 
model came from working with tobacco addictions and expanded to other 
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behavioral problems. Working within the stages of change framework seems to 
require the dedicated attention toward that central, one and only, specifically 
identified problem. As a specific problem is addressed, the individual, along with 
the therapist, monitors that particular stage of change in order to adequately 
adjust the therapeutic intervention.  
The goal is to move through the stages as smoothly as possible. There is 
an acceptance that while working on that problem one could move both 
backward and forward through the stages. So the individual and therapist have 
one problem and five different stages to monitor. The pauper type addict could 
have up to five equally serious problems to address (i.e. housing, employment, 
addiction, medical, and criminal justice). This would require monitoring five co-
evolving problems with five different fluid stages. Because each individual 
problem is influenced and connected to every other problem (e.g. obtaining 
adequate housing would require being able to pay rent, which would also require 
employment, resulting in limiting the time it takes to treat addiction), monitoring 
the stages of change and intervening appropriately would be almost impossible. 
The therapist would have to keep track of five specific and connected problems 
with five different stages for each problem, resulting in at least 25 possible 
intervention opportunities that are constantly evolving and moving in every 
direction (easier said than done!). 
Smoking is a straightforward problem to deal with using the stages of 
change model. It is one problem that can take a back seat when a more serious 
problem arises. Usually it does not require entering into a treatment facility for 
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several hours weekly and lasting several weeks or even months. Treating the 
problem of smoking can also be postponed or even discouraged if a more 
serious problem occurs. Smoking clients are normally not under the pressures of 
going to jail, losing their jobs, being evicted or even losing custody of their 
children for discontinuing the smoking treatment due to a more serious issue 
arising in their lives. It is a matter of prioritizing problems.  
This is not the case with addicts or pauper type addicts who are involved 
in addiction treatment. If they postpone or discontinue addiction treatment, 
serious consequence may ensue. While there could be more serious problems 
arising in the life of pauper type addicts during addiction treatment services, if 
they drop out of those services, it is usually seen as a lack of motivation, or in 
other words, the client is held responsible by being described as noncompliant. 
While the stages of change seemed to be an appropriate framework, it 
may be limiting when dealing with an addicted population with multiple problems 
requiring an array of change stages to monitor. And while Motivational 
Interviewing and the stages of change may rely too heavy on client personal 
agency (an internal motivational flaw), lacking regard for any other external 
forces at work. 
Research Inclusion and Exclusion Activities 
Having re-examined the MI literature to provide more background for the 
intervention, many studies have specific inclusion/exclusion criteria. For example, 
Project MATCH excluded those who were homeless and involved in the criminal 
justice system. A randomized trial in drug abuse services conducted by Miller 
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and Rollnick (2002) provided Motivational Interviewing sessions to patients in 
order to elicit behavior change by exploring and resolving ambivalence. They 
enrolled 152 outpatient and 56 inpatient clients who were entering a public 
agency for drug problems. The researchers reported and excluded clients if they 
reported insufficient residential stability. 
This is not an attempt to take away from the credibility of Motivational 
Interviewing or any Motivational Interviewing research. It seems to work very well 
with specific groups in specific environments. Future interventions must include 
every client entering the facility under study (within the parameters of informed 
consent) or they will not represent real world clinical activities.  
After realizing the weakness of not collecting any baseline data, an effort 
was made to obtain information about subjects’ treatment histories. Because the 
VOA outpatient clinic is funded by SAMSHA-CSAT it is required to treat a 
specific number of clients. SAMSHA-CSAT mandates treatment programs to 
gather baseline data on clients who enter these programs and enter these data 
into SAMSHA-CSAT’s on-line data system, Government Performance and 
Results Act (GPRA). Once a program enters the client’s baseline data into the 
system, SAMSHA-CSAT mandates 6 and 12-month followup with these clients. If 
programs are unable to obtain an 80% followup rate for six and 12 months, the 
program could lose funding. It is recommended that in order to obtain the 80% 
follow up rate, programs must be careful when deciding who they enter into the 
GPRA system. If a client presents as difficult to follow up (e.g., unstable living 
arrangements or homeless, pending legal charges, and/or recent move from out 
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of state) the program may provide treatment, but not enter this hard to followup 
client into the GPRA. 
Of the 106 subjects entering this study, 45 (42.5%) were evaluated to be 
hard to followup clients and not entered into the GPRA database. While they 
were accepted into IOP treatment, the pressure of locating them at 6 and 12 
months was relieved. This practice is not uncommon in research designs, in 
order for research results to be accepted, a specific follow rate is mandated. 
However, the only significant finding resulting from this study was between those 
subjects who were evaluated as hard to follow compared to those subjects 
evaluated as appropriate to enter into the GPRA database and locating at 6 and 
12 months. 
Those subjects entered into the GPRA (those evaluated as being stable 
enough to find at 6 and 12 months) remained in IOP treatment significantly 
longer than those subjects who were evaluated as hard to follow up (t = -5.180, 
p. = .000). The relationship between treatment completion and being entered into 
the GPRA database was also significant. A higher percentage of clients not 
entered into the GPRA (hard to follow) dropped out of treatment compared to 
those who were entered into the GPRA database (Chi-Square = 7.082, df = 1, p 
.008). 
These findings relate back to subject exclusion based on research 
requirements that demand specific followup rates. While subjects meeting 
research inclusion criteria and entered into studies produce higher followup rates 
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and acceptable data analyses, the effects of research exclusion could have 
significant clinical effects on those excluded from research. 
Treatment as Usual 
The final implication is the idea of treatment as usual. This study did not 
speak extensively to the specific treatment being offered to subjects and how it 
relates to generalizable outcomes. An assumption of the current design was that 
everyone receiving treatment as usual served as a control for both groups. Never 
considered was the question of, what is usual treatment? Does treatment as 
usual mean the best evidence-based treatment being offered? The assumption 
made when using treatment as usual is that as long as both groups get it, 
treatment quality does not matter. 
Treatment as usual without examining its quality, limits the study’s 
generalizability, as well as the knowledge needed to inform best practices. For 
instance, if a study was designed to investigate the effects of medication on 
retention and completion within a tuberculosis clinic, treatment as usual would 
have to be the best, medically agreed upon activity. Let’s agree that the standard 
practice for treating and curing tuberculosis consists of taking four anti-
tuberculosis drugs over the course of six months. This would be treatment as 
usual due to its empirically based results. It cures tuberculosis without regard to 
geographic, socio-economic, or basic human demographic differences. The only 
problem with the tuberculosis therapy is that the sufferers are dropping out of the 
treatment regimen. 
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An investigation to understand tuberculosis treatment retention and 
completion would be a worthy cause. Treatment compliance would ensure the 
elimination of tuberculosis. If conducting a study in a tuberculosis clinic it must 
provide these four medications in order to be considered treatment as usual. 
However, let say that due to cost constraint and the inability to treat every case of 
tuberculosis, there is a clinic in town (the Volunteer Clinic) that treats those who 
suffer for tuberculosis who do not have the necessary health care coverage to be 
treated in local prestigious clinics. While this volunteer clinic provides those same 
medications, it cannot afford them in the correct dosage. The volunteer clinic 
provides lower doses of the standard medications resulting in the treatment 
lasting twice as long. Therefore, the six months of treatment now must take a 
year. And for that individual whose untreated tuberculosis has caused greater 
medical complications, receiving the minimum treatment dose over a longer 
period of time cannot be quality care. Could this volunteer clinic be considered 
and studied using treatment as usual? Could the retention and completion 
findings at the volunteer clinic be generalized to other tuberculosis clinics 
providing substandard care? Are there research ethics involved in this real world 
dilemma? (Not to worry, the Institutional Review Boards are concerned with 
protecting people from research—not clinical services.) 
Knowledge building becomes limited without knowing specifically how 
treatment as usual is being used within the research design. Treatment as usual 
should also be evaluated and clarified for its effectiveness on the problem being 
studied before accepted as a controlled research condition. This study, while not 
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taking these issues in account, cannot produce the knowledge for which it was 
searching. 
Future Research 
Future research should address the outside influences on subjects. For 
instance, relying only on an in-treatment intervention without addressing housing 
issues, unemployment, medical conditions, or other overpowering forces 
requiring the immediate attention of the client, would have a limiting effect on 
outcomes. This study could be replicated using a case manager working to 
stabilize outside issues thereby allowing the subject to focus on remaining in 
treatment and only treating addiction. A case manager could assist with limiting 
the pressures of outside issues pulling subjects away from the priorities of 
treatment. 
The same would be true of the addicted HIV-infected population coming 
into treatment. However, following Rounsaville, Carroll, and Onken’s (2001) 
Stage 1b Pilot Trial model for research when including those who are HIV-
infected into addiction treatment would require a greater amount of time in a 
larger study. Because this population usually requires many levels of care as well 
as being hard to follow, enrolling them into research studies demanding rigorous 
followup could be difficult.  
This study was able to adhere to some of the Stage 1b Pilot Trial’s aims. 
Alcohol and other drug addicted HIV/AIDS positive subjects were retained long 
enough to receive the intervention. This study was also able to recruit sufficient 
numbers of the targeted population to deliver the intervention and analyze some 
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data. However, one aim was to obtain a clinically significant outcome on at least 
one important domain, which did not occur. 
The recommendation for future research with a larger sample of those who are 
alcohol and other drug addicted would also apply to those entering HIV-infected. 
Connecting this population with a case manager who understands both disease 
conditions and is able to operate within the community to bring together 
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Description of Volunteers of America of KY Intensive Outpatient 
Alcohol/Drug Treatment  
 
Program Description: The Outpatient Clinic has been designed to offer Gender 
Specific Programming for both men and women who are HIV positive, and/or at 
high risk for HIV and alcohol/drug dependent. The program is to provide persons, 
who are HIV and alcoholic/drug dependent, treatment and case management 
services. There are two separate Intensive Outpatient tracks: one for women and 
one for men the women meet from 9:00 am - 1:00 pm, and the men meet from 
1:00-5:00 pm, Monday through Friday. We offer childcare for both women and 
men who have children while they are in treatment.  
Admission Criteria: Eighteen years or older who are alcohol/drug dependent 
with HIV and/or at high risk for HIV. 
Services Offered: The services provided are gender specific 90 minute group 
counseling sessions, Recovery Dynamics, life skills, vocational and career 
development, parenting classes, health issues, domestic violence counseling, 
intensive case management/outreach services and continuing care services. The 
program also has the capability to provide psychiatric consult and evaluation. We 
also provide childcare services and referrals for child enrichment programs. 
Contact Person(s) Lynda Durrett, Program Manager or Deb Reinhardt, Director 
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STUDY TITLE: Technical assistance and program evaluation (longitudinal 
followup study) of the Volunteers of America targeted expansion initiative for 
substance abuse and HIV prevention in minority communities. (CSAT # TI-14491 & 
TI-15852) 
 
Subject Informed Consent 
 
Introduction and Background Information: You are invited to participate in a research 
study.  
 
The study is being conducted by Richard N. Cloud, Ph.D. and Linda K. Bledsoe, Ph. D. 
The study is sponsored by the University of Louisville Kent School of Social Work and a 
grant from the federal department of Health and Human Services, Substance Abuse and 
Mental Health Services Administration, Center for Substance Abuse Treatment (CSAT) 
that was awarded to Volunteers of America (VOA). Money from the grant is being paid to 
the University of Louisville, Kent School of Social Work to conduct this study. The study 
involves your involvement in two interviews that will take place at the VOA or some other 
agreeable site. Approximately 200 subjects will be invited to participate. Your 
participation in this study will last for one year following treatment. 
 
Purpose: The purpose of this research study is to test effectiveness of the VOA 
treatment program at reducing substance abuse and to reduce practices known to 
spread HIV/AIDS. Your involvement in the study will consist of two interviews expected 
to last about one hour each. These two interviews will be conducted at approximately six 
and twelve months following the date that you started treatment at VOA. 
 
Procedures: At these two interviews, you will be asked to complete many (but not all) of 
the questionnaires that you completed when you signed up for the VOA treatment 
program. One questionnaire includes several questions related to how your life is going 
in general, substance abuse, and practices known to spread HIV/AIDS. In addition, we 
will be asking you to complete four questionnaires that provide information on conditions 
that are known to reduce substance abuse, including: AA and NA involvement; 
motivation to stay clean and sober; support from friends; and temptation to use drugs 
and alcohol. In general, we will compare responses of subjects at the time treatment 
began to responses to the same questions six and twelve months later. You may refuse 
to answer any question that makes you uncomfortable. 
 
Additionally, some people may be asked to participate in one to five more motivational 
counseling sessions in order to see if it increases your retention in treatment services. If 
you agree to participate in these additional interviews, please complete the checkboxes 
below: 
You agree to participate in the additional counseling sessions Initial Here   
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You do not want to be contacted for the additional sessions   Initial Here   
 
Potential Risks: There is a risk that participating in the study could lead to a breach in 
confidentiality. This means people could learn of your participation in the study. Since 
the program is treating substance abuse among those who have HIV and those at risk of 
contracting HIV, this information could result in some form of discrimination. For this 
reason, it is critical that you are careful to maintain absolute confidentiality of the other 
participants in treatment. We are taking several steps to safeguard confidentiality of 
participants. In addition, some of the questions on illicit drug use and sexual practices 
could be incriminating. Because of this we have sought legal protection to reduce a 
highly unlikely risk that a court might subpoena these records (see Certificate of 
Confidentiality below). In addition, there may be unforeseen risks that cannot be 
anticipated. 
 
Certificate of Confidentiality: To help us protect your privacy, we have obtained a 
Certificate of Confidentiality from the federal government. With this Certificate, the 
investigators cannot be forced (for example by court subpoena) to disclose your name or 
other information that may identify you in any federal, state, or local civil, criminal, 
administrative, legislative, or other proceedings. The Department of Health and Human 
Services (DHHS) may see your information (only for audit or program evaluation), and 
we may voluntarily disclose information if we think harm to yourself or others, including 
child abuse, is probable. None of this implies DHHS approval or disapproval. 
If an insurer, employer, or other person obtains your written consent to receive research 
information, then the researchers may not use the Certificate to withhold that 
information. The Certificate of Confidentiality does not prevent the researchers from 
disclosing voluntarily, without your consent, information that would identify you as a 
participant in the research project under the following circumstances: if we should 
become aware of any act of child abuse, or any intent to harm yourself or another 
person during the course of the interview.  
 
Confidentiality: Although absolute confidentiality cannot be guaranteed, we are taking 
steps and are committed to protecting your privacy. The study sponsor, the Institutional 
Review Board (IRB), the Human Subjects Protection Program Office (HSPPO), 
personnel conducting the research including those from the Kent School of Social Work 
may have access to research records. Should the data collected in this research study 
be published, your identity will not be revealed.  
 
Benefits: The possible benefits of this study include helping VOA to do the research that 
they agreed to do in their agreement with CSAT, which in turn, will help to insure that 
VOA continues to receive money to pay for future substance abuse treatment services 
benefiting both you and others. In addition, while the information collected may not 
benefit you directly, what is learned may benefit VOA and American society by leading to 
improved methods to treat substance abuse and to reduce the spread of HIV.  
Compensation: You will receive $20 for completing the six-month and the twelve-month 
interviews ($20 for each interview or $40 for both interviews). Those agreeing to 
participate in the additional counseling will not be paid extra. 
 
Voluntary Participation: Your participation in this research study is voluntary. You may 
refuse to participate and you are free to withdraw your consent at any time without 
penalty or losing benefit to which you are otherwise entitled.  
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Research Subject’s Rights and Contact Persons: You acknowledge that all your present 
questions have been answered in language you can understand and all future questions 
will be treated in the same manner. If you have any questions about the study, please 
contact Richard N. Cloud, Ph.D. at 502-299-1385. 
 
If you have any questions about your rights as a research subject, concerns or 
complaints about the research or research staff, you may call the HSPPO at 502-852-
5188. You will be given the opportunity to discuss any questions about your rights as a 
research subject, in confidence, with a member of the IRB. The IRB is an independent 
committee composed of members of the University community, staff of the institutions, 
as well as lay members of the community not connected with these institutions. The IRB 
has reviewed this study.  
 
Consent: You have discussed the above information and hereby consent to 
voluntarily participate in this study. You will be given a signed copy of the 
consent. 
 
___________________________________________   ___________ 
Signature of Subject        Date Signed 
 
___________________________________________   __________ 
Person Explaining the Consent      Date Signed 
 
___________________________________________   ___________ 
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Motivational Interviewing 
Protocol for Sessions on Retention 
Sources of Non-Adherence Motivational Strategies 
 
Uncertainly or ambivalence 
about change 
 
Persistent empathy and non-defensiveness 
Concerns about the suitability 
of the treatment modality 
offered 
 
Normalizing gradual development of trust 
Misperceptions about treatment 
needs 
 
Exploring understanding of how treatment 
works 
Previous negative treatment 
experiences 
 
Eliciting perceptions of treatment needs 




Culture-specific differences Reviewing past treatment experiences 
Stigma Exploring and addressing previous and future 
barriers to change in treatment 
Mandated treatment/coercion 
 
Negotiating proximal goals 
High barriers to care (financial 
problems, family hardships) 
 
Communicating a non-perfectionist message 
Recognizing non-adherence as a sign of 
damaged rapport 
 
Addressing breeches in rapport 
 
Involving a supportive other for motivational 
support 
 
Identifying positive experiences of receiving 
help 
 
Supporting self-efficacy or coping capacities 













DAVID A. PATTERSON 
Silver Wolf (Adelv unegv Waya) 
2955 Brownsboro Road 
Louisville, KY 40206 
(502) 819-2255 Cell 





University of Louisville/University of Kentucky 
Kent School of Social Work Ph.D. Program 
5/2003 to Present (Defense 4.20.2006) 
 
University of Louisville, Kent School of Social Work 
8/1996 to 12/1997 
Degree: Masters of Science in Social Work (MSSW) 
 
Spalding University 
1/1994 to 5/1996 
Degree: Bachelors of Science in Social Work (BSW) 
 
Jefferson Community College 




Certified Alcohol and Drug Counselor (CADC) since 12/1996 
Certified Social Worker (CSW) 1998 to 2003 
Recovery Dynamics Trainer since 5/1992 




University of Louisville 
Co-Investigator/Research Coordinator 7/05 to Present 
See details below under “Contracts and Grants” 
Volunteers of America of Kentucky and Tennessee 
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Manager -- Outreach & Motivational Counseling Services 11/03 to 7/05 
(Funded by Center for Substance Abuse Treatment, CSAT) Manage newly 
funded five-year program ($398,195 yearly) designed to offer outreach services 
and Motivational Interviewing sessions in order to address treatment retention 
issues.  
 
Responsible for the overall management of three programs and services (total 
budget approx. $1 million yearly) 9/02 to 11/03: 
 
Intensive Outpatient Programs Services Manager  
(Funded by Center for Substance Abuse Treatment, CSAT) Manage Intensive  
Outpatient Program which provides alcohol and drug treatment services for 
individuals needing those specific services, and whom are considered high-risk 
for HIV/AIDS or currently HIV/AIDS positive.  
 
STOP HIV-Out-Reach Manager  
(Funded by Center for Disease Control and Prevention, CDC) Manage STOP 
Out-Reach staff consisting of six out-reach prevention specialists and two 
prevention case managers who provide services to men having sex with men, 
gay men of color, high risk minority heterosexuals and intravenous drug users.  
  
HOPWA Manager  
(Funded by Housing and Urban Development, HUD) Management of Housing 
Opportunity for Persons With AIDS (HOPWA) consisting of providing rental, 
clothing, alcohol and drug services, food & travel vouchers, as well as other 
human services related assistance for HIV-infected individuals.  
  
Patterson & Associates (P&A) 
Owner 2/2002 to Present 
Provides individual, couple, family counseling; employee assistance programs & 
work life services; along with training & educational workshops. 
 
Wood-IN, LLC 
General Manager 3/1999 to 9/2002 
Responsible for all aspects of family-owned wood manufacturing operations 
(average $175,000 monthly sales).  
 
Volunteers of America of KY 
HIV Out-Reach Manager & Third Step Program Manager 3/1998 to 3/1999 
Managed two programs, the Third Step Program is a long-term alcohol and drug 
treatment facility that provides assessments, individual and group therapy, 
recovery related lectures, and family therapy. The HIV Out-Reach Program 
focuses on working in the community (jails, shelters, hospitals, & social services 
agencies) to identify the target population of the grant, i.e. sero-positive persons 
with alcohol and drug problems.  
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Jefferson County Attorney’s Office 
Adult & Juvenile Drug Court Diversion Program 
Program Leader 7/1996 to 3/1998 
Designed and implemented program policies and procedures, coordinated 
community resources, developed program curriculum, supervised counselors 
and out-reach workers.  
 
Volunteers of America of Kentucky’s Third Step Program 
Counselor II 12/1994 to 7/1996 
Counselor I  8/1993 to 12/1994 
Resident Manager 6/1991 to 8/1993 
Provided assessments, case management, individual & group therapy, prepared 
and delivered recovery lectures, developed individual treatment plans, and 
referrals for community-based services.  
 
PAST & PRESENT MEMBERSHIPS 
 
University of Louisville’s Human Protection Committee’s International Review 
Board (IRB) Social & Behavioral Committee Member, current  
Applied Research Ethics National Association Member (ARENA), current  
National Association of Alcohol and Drug Addiction Counselors (NAADAC) 
Member since1996  
National Association of Social Workers (NASW) Member 1996 to 2003 
AIDS Service Center Coalition (ASCC) Board Member, current  
People Advocating Recovery (PAR) Member, current  
The Cherokee Tribe of Kentucky, current 
Smithsonian's National Museum of the American Indian (NMAI) Sky Meadows 
Circle Charter Member, current 
Cherokee National Historical Society Member, current 
National Trail of Tears Association Member, current 
President, Kentucky Association of Addiction Professionals (KAAP) Louisville 
Chapter – Served two year term 1996 to 1998 
President-Elect, Kentucky Association of Addiction Professionals (KAAP) 
Louisville Chapter – Served two year term 1994 to 1996 
Editor, KAAPsule News Letter – Served two year term 1995 to 1997 
 
AWARDS & TRAINING FELLOWSHIPS 
 
National Institute of Health’s (NIH) Ruth L. Kirschstein National Research 
Service Award Minority Predoctoral Fellowship Program. A Predoctoral 
fellowship funding my dissertation research on the effects of a motivational 
intervention on treatment retention and completion issues for HIV-infected 
alcoholics receiving intensive outpatient services (Scored twice). 
 
2005 June, Center for Disease Control/Association for Schools of Public 
Health, Institute for HIV Prevention Leadership Training: Adapting and 
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Tailoring Evidence-Based Interventions. Three day all expense paid training in 
Atlanta Georgia. 
 
2005 PRICE Fellowship. A fellowship in Atlanta, Georgia at the Center for 
Disease Control and Prevention (CDC) facility. The Price Fellowships program 
offers the opportunity to three individuals from community-based and/or non-
governmental organizations (CBO/NGOs), committed to preventing HIV infection, 
to work closely for one month with health professionals at CDC. (National 
finalist).  
 
2004 Center for Disease Control/Association for Schools of Public Health, 
Institute for HIV Prevention Leadership. A comprehensive, capacity building 
educational program offered over a period of nine months and includes four 
weeks of on-going instructions provided once every quarter in Atlanta, GA. 
 
2004 PRICE Fellowship Reviewer. Reviewed applications for the Center For 
Disease Control and Prevention’s (CDC) 2004 Price Fellowships for HIV 
Prevention. 
 
Research Assistantship. Awarded full tuition reimbursement while obtaining a 
Ph.D. 
 
Spalding University Irish Initiative Scholarship. Received funds to travel and 
study and research social services in Cork, Ireland during the month of March 
1996. 
 
Spalding University Leadership Scholarship 1994. Awarded tuition 
reimbursement while obtaining a BSW. 
 
Volunteers of America’s 1992 Volunteer Of The Year. Provided over 2000 
hours of volunteer services in 1991 within alcohol and drug programs. 
 
PUBLICATIONS IN PEER REVIEWED JOURNALS 
 
Cloud, R. N., Besel, K., Bledsoe, L., Golder, S., McKiernan, P., Patterson, D. A., 
& Ziegler, C. (Forthcoming). Using brief Motivational Interviewing techniques to 
increase post treatment twelve-step meeting attendance: Opportunities and 
challenges. Alcoholism Treatment Quarterly, 24(3). 
 
Patterson, D. A., Cloud, R. N., & McKiernan, P. M. (2004). Treating addicted 
HIV patients: The case for Motivational Interviewing. Counselor, 5, 33-39. 
 
ARTICLE UNDER REVISE and RESUBMIT 
 
Patterson, D. A. Analyzing HIV/AIDS and Addiction as a Social Problem. Journal 
of Psychology & Human Sexuality. 
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RESEARCH & DATA ANALYSIS UNDERWAY 
 
Barve, S., & Patterson, D. A. Analysis of data from India (n=approximately 1300) 
of those who are HIV-infected, positive for TB, alcoholics and non-alcoholic, 
along with other medical data related to health issues in that country. 
 
Cloud, R. N., McKiernan, P. M., & Patterson, D. A. Title: Developing a protocol 
of how social work colleges can assist substance abuse agencies in improving 
practice: A pilot study sponsored by the Volunteers of America of KY and TN. A 
pretest posttest experimental design exploring whether student involvement 
using the most basic motivational interviewing spirit affects program retention 
and after care compliance within three alcohol and drug residential programs for 
men. 
 
Cloud, R. N., McKiernan, P. M., Patterson, D. A., & Cooper, L. Effects of 
substance abuse treatment on patients who are HIV-infected or at a heightened 
risk for HIV. The first year cohort (n=approximately 130) has been followed up on 
several outcomes (e.g. substance use, sexual practices, self efficacy over AoD 
use, motivation to change, enhanced friendship, networks, involvement in 12-
step programs) at baseline and six months post-intake. Initial data analysis has 
been initiated on this follow-up interval. These subjects will also be followed up at 
the one-year post intake. This is a five-year evaluation of treatment study 
sponsored by SAMHSA and Volunteers of America of KY and TN.  
 
Cooper, L., Cloud, R. N., Hill, J., McKiernan, P., & Patterson, D. A. Results of a 
focus group of HIV-infected clients describing reasons that may contribute to 
substance abuse treatment dropout. Research sponsored by SAMHSA and 
Volunteers of America of Kentucky and Tennessee. 
 
Besel, K., Cloud, R.N., Hill, J., McKiernan, P., Cooper, L., & Patterson, D.A. 
Analysis of qualitative interviews describing barriers to initiation of substance 




Fall, 2005: Adjunct Professor, University of Louisville’s Kent School of 
Social Work.  
SW 668 Advanced Research Practice I (Core Course). Three credit hours 
 
Summer, 2005: Adjunct Professor, University of Louisville’s Kent School of 
Social Work.  
SW 697 Motivational Interviewing (Elective Course). Three credit hours 
 
Spring, 2005: Adjunct Professor, Spalding University School of Social Work 
Louisville KY.  
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SW 420 Chemical Dependency (Core Course). One credit hour. 
SW 616 Addiction in Society (Core Course). One credit hour. 
 
Fall, 2004: Co-Teaching. University of Louisville’s Kent School of Social Work.  
SW 697 Motivational Interviewing (Elective Class). Mentor: Richard N. Cloud, 
MSW, Ph.D. 
 
Spring, 2004: Teaching Practicum. University of Louisville’s Kent School of 
Social Work. SW 605 Foundation Generalist Practice II (Core Course). Mentor: 
Seana Golder, MSW, Ph.D. 
 
TRAININGS & INVITED PRESENTATIONS 
 
Alcohol and Drug Diagnosis Presentation: Spring 2005 (2 hour presentation), 
MSSW Course Psychopathology, Dr. Stanley Frager, Kent School of Social 
Work. 
 
HIV & Addiction: Healing the Brain and the Body: 2004 African American and 
Hispanic Leadership Conference on HIV/AIDS. September 2004  
 
The Addicted HIV-Infected Individual: 2003 African American and Hispanic 
Leadership Conference on HIV/AIDS. September 2003.  
 
Neurotherapy: Understanding the Brain’s Impact on Treating Alcoholism. 
University of Louisville Kent School of Social Work’s Spring Conference 2003. 
 
Basic Alcohol and Drug Information. Kentucky Cabinet for Family & Children. 
January 1999.  
 
Volunteers of America of Kentucky & Tennessee Training Institute 
Basic Counseling Theories. April 2004.  
Professional Interventions that Facilitate 12-Step Involvement. January 2004.  
Basic, Intermediate, and Advanced Group Counseling. February 2003.  
Special Populations in Treatment: HIV, Women, & Criminal Justice Clients. 
November 2003.  
Neurotherapy. November 2002. 
 
Recovery Dynamics Trainings 
Volunteers of America’s Third Step Program. 1992 
Volunteers of America’s Freedom House 1993 
Volunteers of America’s Hope House 1994 
Indiana Department of Correction’s Branchville Prison 1994 
Paducah KY’s Alcohol and Drug Treatment Clinic 1994 
Jefferson County Medical Society 1995 
Louisville KY’s Charter Hospital 1995 
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Jefferson Alcohol and Drug Abuse Clinic 1996  
Kentucky Drug Court Programs 1997 
 
CONTRACTS & GRANTS 
 
NIH-NIAAA grant application: Mechanisms of Alcohol-Induced 
ImmunoSuppression (R01 AA014371-01A1) Test the effects of ethanol on 
PBMCs/CD4+T-cells obtained from alcoholic patients and abstinent, healthy 
control subjects. The efficacy of exogenous SAMe supplementation in 
attenuating CD4+T-cell death induced by alcohol will also be determined. (Five 
year award, University of Louisville School of Medicine, Sept. 2004 to June 2009)  
Role: Sub-Investigator. 
 
NIH-NIAAA grant application: Improving posttreatment Alcoholics Anonymous 
utilization in response to (1 R03 AA14578-01A1; $73,000 for two years, including 
indirect, or $146,000 total). Testing an intervention consisting of two components, 
a brief motivational session combined with a recovery mentor, to improve 
posttreatment involvement in twelve step programs. (Two year award, University 
of Louisville School of Social Work, May 2004 to Apr 2006) Role: Co-
Investigator/ Research Coordinator. 
 
Substance Abuse and Mental Health Services Administration-Center for 
Substance Abuse Treatment contract with Volunteers of America of Kentucky 
(CSAT #TI-14491-01; Grantee Project Name: Gender Specific Intensive 
Outpatient Program for HIV; $79,920 per year renewable for five years beginning 
10/1/2002; $399,600 total, plus $8,150 supplement during the first year totaling 
$407,750). Goal: Addiction treatment for those who are HIV positive or at high 
risk. Role: Co-Investigator/ Research Coordinator. 
 
Substance Abuse and Mental Health Services Administration-Center 
for Substance Abuse, Center for Substance Abuse Treatment contract with 
Volunteers of America (CSAT #TI 03-008; $68,000 for five years or $340,000 
total; 12.5% FTE; first year award began 10/1/2003). Goal of grant: Addiction 
treatment outreach to people who are HIV positive. Role: Co-Investigator/ 
Research Coordinator.  
 
Kentucky Cabinet for Health Services (CHS), Department for Public Health’s 
(DPH) cooperative agreement funds from the Center for Disease Control and 
Prevention (CDC) focusing on HIV prevention. Responded to a Request For 
Proposal while at the Volunteers of America and awarded $41,500 for one 
Prevention Specialist and supplies targeting Minority/High Risk Heterosexuals. 
(One year contract, Volunteers of America of KY & TN, starting August 2003 
Document #S-03261411). Role: Grant writer, Manager.  
 
Kentucky Housing and Urban Development’s (HUD) Housing Opportunities for 
Persons With AIDS (HOPWA). Responded to a multi-site Request For Proposal 
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while at the Volunteers of America and awarded approximately $300,000 for 
rental assistance and other services specifically for HIV-infected persons. (Three 
year contract, Volunteers of America of KY & TN, starting February 2004). Role: 
Grant writer. 
 
Kentucky Cabinet for Health Services (CHS), Department for Public Health’s 
(DPH) cooperative agreement funds from the Center for Disease Control and 
Prevention (CDC) focusing on HIV prevention. Responded to a Request For 
Proposal while at the Volunteers of America and awarded $714,400 for eight 
Prevention Specialists and supplies targeting Men who have Sex with Men 
(MSM), Intravenous Drug Users (UDI), Minority/High Risk Heterosexuals (HRH), 
and Two HIV+ Prevention Case Managers. (Two year contract, Volunteers of 
America of KY & TN, starting April 2004 Document #S-0343912). Role: Grant 
writer. 
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